UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-KSB
(Mark One)
|X| ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
For the fiscal year ended December 31, 2005
Or
|_| TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition period from ____________to___________
Commission file number: 000-26703
Union Dental Holdings, Inc.
--------------------------------------------
(Name of small business issuer in its charter)
Florida 65-0710392
------------------------------------- --------------------------------
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
1700 University Drive, Suite 200
Coral Springs, Florida 33071
------------------------------------- --------------------------------
(Address of principal executive offices) (Zip Code)
Issuer's telephone number: (954) 575-2252
Securities registered pursuant to Section 12(b) of the Exchange Act: None
Securities registered pursuant to Section 12(g) of the Exchange Act:
Common Stock, Par Value $0.0001 Per Share
Check whether the issuer (1) has filed all reports required to be filed by
section 13 or 15(d) of the Exchange Act during the past 12 months (or for such
shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days.
Yes |X| No ||
Check if there is no disclosure of delinquent filers in response to Item
405 of Regulation S-B is not contained in this form, and no disclosure will be
contained, to the best of registrant's knowledge, in definitive proxy or
information statements incorporated by reference in Part III of this Form 10-KSB
or any amendment to this Form 10-KSB. |X|
Indicate by check mark whether the registrant is an accelerated filer (as
defined in Rule 12b-2 of the Act). Yes |_| No |X|
State issuer's revenues for its most recent fiscal year ended December 31,
2005: $2,066,944.
Of the 35,334,2999 shares of common stock of the registrant issued and
outstanding as of March 1, 2006 approximately 17,959,299 shares were held by
non-affiliates. The aggregate market value of the voting stock held by
non-affiliates of the registrant computed by reference to the closing bid price
of its Common Stock as reported on the OTC Bulletin Board on March 1, 2006 was
$1,616,337.
DOCUMENTS INCORPORATED BY REFERENCE
Form SB-2 filed on September 9, 2005
Transitional Small Business Disclosure Format (check one): Yes |_| No |X|
PART I
The following discussion should be read in conjunction with the Company's
audited financial statements and notes thereto. In connection with, and because
the Company desires to take advantage of, the "safe harbor" provisions of the
Private Securities Litigation Reform Act of 1995, the Company cautions readers
regarding certain forward looking statements in the following discussion and
elsewhere in this report and in any other statement made by, or on its behalf,
whether or not in future filings with the Securities and Exchange Commission.
Forward-looking statements are statements not based on historical information
and which relate to future operations, strategies, financial results or other
developments. Forward looking statements are necessarily based upon estimates
and assumptions that are inherently subject to significant business, economic
and competitive uncertainties and contingencies, many of which are beyond the
Company's control and many of which, with respect to future business decisions,
are subject to change. These uncertainties and contingencies can affect actual
results and could cause actual results to differ materially from those expressed
in any forward looking statements made by, or on the Company's behalf. Without
limiting the generality of the foregoing, words such as "may", "anticipate",
"intend", "could", "estimate", or "continue" or the negative or other comparable
terminology are intended to identify forward-looking statements. The Company
disclaims any obligation to update forward-looking statements.
Item 1. Description of Business
(a) Business Development. National Business Holdings, Inc., a Florida
corporation, was incorporated on November 26, 1996 as Stirus Research &
Development, Inc. We were originally in the business of development and sales
distribution of medical devices. We later changed our name to Mecaserto, Inc. on
November 9, 1998, when we acquired a French subsidiary, Mecaserto, S.A., whose
business was the manufacture and sale of a medical imaging device.
On or about May 1, 2002, Pieter Durand, our former officer and director,
loaned us $25,000 to support our working capital requirements. This indebtedness
was evidenced by a Convertible Note, convertible into our Common Stock at the
election of the holder. Pursuant to the December 27, 2004 Reorganization
Agreement, this debt has been canceled.
On or about May 5, 2003, our French subsidiary faced liquidation in a
French court and we relinquished our ownership interest in this subsidiary to
our French shareholders in exchange for such holders' agreement to assume the
debts and liabilities of the French subsidiary. Since the conclusion of this
transaction and prior to our reorganization with Union Dental Corp and Direct
Dental Services on December 27, 2004, we had no assets, liabilities or business
operations except our Convertible Note indebtedness and miscellaneous payables.
On or about February 2, 2004, we accepted a subscription from Gala
Enterprises Ltd. for 10,000,000 shares of our restricted, unregistered common
stock for cash proceeds of $25,000 in order to support our short-term working
capital requirements. We relied upon Section 4(2) of the Securities Act of 1933,
as amended ("Securities Act"), and Rule 506 of Regulation D promulgated
thereunder. This transaction did not involve a public offering and was exempt
from registration under the Securities Act. No underwriters were used in
connection with this transaction.
3
On February 2, 2004, Pieter Durand, the principal of Gala Enterprises Ltd.,
was appointed to serve as a member of our Board of Directors until the next
meeting of the shareholders in which directors are elected. Subsequently, on
February 6, 2004, Dennis Rault, our former sole officer and director, tendered
his resignation, leaving Mr. Durand as our sole officer and director.
On May 4, 2004, our Board of Directors ratified and accepted and the
majority shareholders approved by written consent an Amended and Restated
Articles of Amendment to the Articles of Incorporation, filed with the State of
Florida on May 11, 2004, changing our name from Mecaserto, Inc. to National
Business Holdings, Inc. Our Restated Articles of Incorporation allow us to issue
up to 300,000,000 shares of common stock, par value of $.0001, of which
29,510,585 shares are issued and outstanding at the present time. The Restated
Articles of Incorporation also allow us to issue up to 25,000,000 shares,
$0.0001 par value, of preferred stock with the specific terms, conditions,
limitations and preferences to be determined by the Board of Directors without
shareholder approval, of which 1,000,000 shares are issued and outstanding at
the present time.
On May 10, 2004, our Board of Directors ratified and accepted and a
majority of shareholders approved by written consent a subdivision of the issued
and outstanding common stock of the Company (a reverse split) at a ratio of one
(1) share for each forty (40) shares of common stock issued and outstanding,
effective May 24, 2004.
On May 28, 2004, we entered into a Share Exchange Agreement with Shava,
Inc. ("Shava"), whereby we acquired one hundred percent (100%) of all the
outstanding shares of common stock ("Shava Common Stock") of Shava from Roger E.
Pawson, Shava's sole officer, director and shareholder, in exchange for
3,100,000 post-reverse split shares of our common stock in order to effect a
reverse acquisition of Shava. As a part of the transaction, the Company changed
its fiscal year end from December 31 to May 31. We filed a Form 10-KSB for the
transition period from January 1, 2004 to May 31, 2004 in accordance with the
Securities Exchange Act of 1934.
After the May 28, 2004 change in control, we decided to initiate a new
business plan of lending and investing. In June 2004, we formed a new wholly
owned subsidiary in Florida, National Business Investors, Inc. with headquarters
in Falls Church, Virginia and San Diego, California. This subsidiary has not
conducted any business to date.
On December 27, 2004, we entered into a Share Exchange and Reorganization
Agreement ("Reorganization") with both Union Dental Corp, a Florida corporation
("UDC") and Direct Dental Services, Inc., a Florida corporation ("DDS") whereby
UDC and DDS became wholly-owned subsidiaries of us in exchange for an aggregate
of 17,500,000 shares of our common stock and 1,000,000 shares of our preferred
stock with each share of preferred stock providing voting rights equal to 15
shares of our common stock. In addition, we agreed to recognize the 3,452,250
issued and outstanding options to purchase UDC common stock as options to
purchase our common stock. Pursuant to the Reorganization Agreement, 22,287,977
shares of our common stock were canceled.
Effective October 15, 2004, UDC acquired substantially all of the assets
(except the patient list) of George D. Green D.D.S., P.A. in Coral Springs,
Florida. Pursuant to this Asset Purchase Agreement, the aggregate purchase price
4
payable by UDC for these assets was One Million Dollars ($ 1,000,000.00) ,
payable pursuant to a Promissory Note (the "PA Note") in the amount of One
Million Dollars ($1,000,000.00) with interest thereon of five percent (5%) per
annum, and which note shall be payable in ten (10) equal yearly installments.
DDS operates a network of duly licensed dental providers (the "Dental
Referral") who provide dental services through the network to union members in
accordance with arrangements between DDS and various unions. Pursuant to the
Stock Purchase Agreement, on August 14, 2000, Dr. Green acquired two hundred
fifty (250) shares of common stock of DDS from Melvyn Greenstein, DDS and Irene
Greenstein, the initial shareholders and Sellers (collectively the
"Greensteins"), for the purchase price of One Million Eight Hundred Fifty
Thousand Dollars ($1,850,000.00) (1st DDS Purchase Price"). The 1st DDS Purchase
Price was payable as follows: One Million Four Hundred Fifty Thousand Dollars
($1,450,000.00) at closing and a promissory note of Four Hundred Thousand
Dollars ($400,000.00). On December 31, 2003, Dr. Green acquired the remaining
two hundred fifty (250) shares of common stock of DDS from the Greensteins for
the purchase price of Eight Hundred Fifty Thousand Dollars ($850,000.00) (2nd
DDS Purchase Price"). As a result of the 1st DDS Purchase Price and the 2nd DDS
Purchase Price, Dr. Green owned of record and beneficially all of the issued and
outstanding common stock of DDS, consisting of five hundred (500) shares of DDS.
On January 11, 2005, we amended our Articles of Incorporation to change our
name from National Business Holdings, Inc. to Union Dental Holdings, Inc. On
February 8, 2005, we further amended our Articles of Incorporation to issue
1,000,000 shares of preferred stock with each share of preferred stock providing
voting rights equal to 15 shares of our common stock to Dr. Green.
On May 17, 2005, Union Dental Holdings, Inc., a Florida corporation (the
"Company"), entered into an Asset Purchase Agreement to acquire certain assets
and assume certain liabilities of DORA VILK-SHAPIRO, D.M.D., P.A. d/b/a Dental
Visions, a Florida corporation ("Dental Vision") for a purchase price of
$283,241 ("Purchase Price"). However, Dental Vision's patient list shall be
assigned to George D. Green. The patient list is assigned to Dr. Green for
partial consideration for personally guaranteeing the Company's bank loan. The
Purchase Price consists of the Company assuming debt in the amount of $169,486
and the issuance of 733,901 shares of the Company's common stock, valued at 15.5
cents per share for an aggregate price of $113,755 (the "Acquisition"). The
Asset Purchase Agreements contains customary representations and warranties,
closing and termination provisions. The closing relating to the Dental Vision
assets occurred upon entry into the Asset Purchase Agreement.
On August 17, 2005, we entered into an Investment Agreement with Dutchess
Private Equities Fund II, L.P.. Pursuant to this Agreement, Dutchess will commit
to purchase up to $5,000,000 (the "Line") of our Common Stock over the course of
36 months ("Line Period"), after a registration statement has been declared
effective by the SEC (the "Effective Date"). The amount that we shall be
entitled to request from each of the purchase "Puts", shall be equal to either
(1) $100,000 or (2) 200% of the averaged daily volume (U.S market only) ("ADV")
of our Common Stock for the 20 Trading days prior to the "Put" notice,
multiplied by the average of the 3 daily closing prices immediately preceding
5
the Put Date. The Pricing Period shall be the five (5) consecutive trading days
immediately after the Put Date. The Market Price shall be the lowest closing bid
price of the Common Stock during the Pricing Period. The Purchase Price shall be
set at 95% of the Market Price. The Put Date shall be the date that the Investor
receives a Put Notice of draw down by us of a portion of the Line. There are put
restrictions applied on days between the Put Date and the Closing Date with
respect to that Put. During this time, we shall not be entitled to deliver
another Put Notice. We shall automatically withdraw that portion of the put
notice amount, if the Market Price with respect to that Put does not meet the
Minimum Acceptable Price. The Minimum Acceptable Price is defined as 75% of the
lowest closing bid price of the common stock for the ten (10) trading day period
prior to the Put Date.
In December 2005, we executed a promissory note in favor of Dutchess in the
amount of $960,000 and received gross proceeds in the amount of $800,000 less
$60,075 in fees for net proceeds of $739,925. We are obligated to repay the face
amount of the loan on or before December 23, 2006. We make payments to Dutchess
from each Put notice uner our equity line of credit. We are obligated to pay
Dutchess the greater of a) 50% of each Put notice or b) $80,000 until the face
amount of the loan obligation has been repaid. We issued 50 signed Put notices
to the Investor to use as collateral.
During the fiscal year ended December 31, 2005, we did not make any Put notices.
Debenture Agreement
Also on August 17, 2005, we sold $600,000 in principal amount of our five
year convertible debentures to Dutchess Private Equities Fund II, L.P. These
debentures bear interest at 10% per annum (payable in cash or stock at Dutchess'
option). Our obligation to repay Dutchess is secured pursuant to the terms of a
security agreement, which we have entered into with Dutchess. We have pledged
all of our assets to insure repayment of the Debenture. Dutchess' security
interest in our assets will be subject to any claims by our bank, which provides
us with a line of credit. The conversion price of the debenture shall be $.092
per share or; the lowest closing bid price of the common stock during the
fifteen trading days prior to the filing of this Registration Statement with the
SEC covering the shares issuable on the underlying debt. We also issued Dutchess
a warrant to purchase 1,304,348 shares of common stock with a strike price of
$.092 per share. The warrant may be exercised for a period of five years.
During the year ended December 31, 2005 Dutchess converted a total of
$59,231.15 in convertible debt and interest and we issued to Dutchess a total of
643,817 shares of our common stock at a conversion price of $.092 per share.
Unless the context indicates otherwise, references hereinafter to the
"Company", "we", "us" or "Union" include both Union Dental Holdings, Inc., a
Florida corporation and our wholly owned subsidiaries, Union Dental Corp., a
Florida corporation, Direct Dental Services, Inc., a Florida corporation. Our
principal place of business is 1700 University Drive, Suite 200, Coral Springs,
Florida 33071, and our telephone number at that address is (954) 575-2252.
(b) Business of the Company. During the fiscal year ended December 31,
2005, we operated two business lines: operating a network of duly licensed
dental providers to a network of union members through DDS and managing a dental
practice through UDC.
6
DIRECT DENTAL SERVICES, INC.
Direct Dental Services, Inc. ("DDS") is a Florida corporation that operates
a network of duly licensed dental providers (the "Dental Referral") who provide
dental services through the network to union members in accordance with
arrangements between DDS and various labor unions. DDS is not limited as to the
type of labor union which DDS may solicit. DDS charges a annual management
services fee to the participating dentists to practice in an "area of
exclusivity" for union members. DDS currently has exclusive contracts with local
unions, such as Communications Workers of America ("CWA"), International
Brotherhood of Electrical Workers ("IBEW") and General Electric's International
Union of Electronic, Electrical, Salaried, Machine and Furniture Workers -
Communications Workers of America ("IUE-CWA").
Members of the Dental Network are assigned "areas of exclusivity"
established by DDS which grants the Dental Network provider primary
responsibility to provide for the general dentistry and specialist services
required by covered union members. DDS's Network dentists accept as payment in
full for covered services the scheduled amount payable by the applicable union
sponsored dental benefit plan together with a relatively small co-payment from
the covered union member. The copayment to be paid by the union member is
generally substantially lower than the scheduled copayment set forth in the
applicable dental benefit plan, resulting in significant savings to the union
member.
EXCLUSIVE AGREEMENTS
DDS selects certain dentists in selected geographical areas to represent
DDS. The dentists enter into an exclusive agreement with DDS for an annual
management services which typically range from $3,000 to $6,000. The specific
fee which we charge is based on each specialty the dentist provides to the
patients on a per office basis. Significantly lower fees may be charged for
dental practices covering a large geographic area which employ a large number of
participating dentists. We believe that this practice will provide us with
greater exposure to the unions, dentists and the public. DDS receives a yearly
membership fee from each dentist in order for him/her to maintain the exclusive
area of each specialty that the dentist provides. Currently, areas of
specialties include: (1) General Dentistry (2) Orthodontics (3) Periodontics (4)
Pedodontics (5) Endodontics (6) Prosthodontics (7) Oral & Maxillofacial Surgery,
(8) Implants and (9) TMJ.
DDS enters into contracts with labor unions to be the exclusive provider of
dental services to its memberships under existing dental benefit plans.
Presently, DDS has a contract with the CWA covering its members in 19 states,
including employees of AT&T, Lucent, Avaya, Verizon, Bell South, Cingular and
SBC/Pactell. We also entered into agreements with the International Brotherhood
of Electrical Workers Local #824 in Tampa, Florida and Local # 728 in Ft.
Lauderdale, FL and General Electric's International Union of Electronic,
Electrical, Salaried, Machine and Furniture Workers - Communications Workers of
America Local 761 in Louisville, Kentucky. We intend to pursue other labor
unions as part of our expansion program.
DENTAL NETWORK
The Dental Network currently consists of approximately 1,100 licensed
dentists located in 12 states. The territory served by the Dental Network is
divided into geographic areas using a predetermined formula that allocated
7
approximately one general dentist to approximately 1,100 to 1,200 insured union
employees which includes their immediate family members. Exclusive areas for
specialists are allocated approximately 6,000-8,000 insured union employees,
which includes their immediate family members, per specialist. Each member of
the Dental Network enters into an annual network provider agreement with DDS for
his or her respective Exclusive Area. Consideration paid by the Dental Network
member is determined based upon the size of the Exclusive Area and the number of
specialties covered under the respective member's contract.
UNION DENTAL CORP.
Union Dental Corp., ("UDC") is a Florida corporation that has acquired the
assets (minus the client list) of Dr. George D. Green, P.A. effective October
15, 2004. Subsequent thereto, on May 17, 2005, UDC acquired certain assets and
assumed certain liabilities of DORA VILK-SHAPIRO, D.M.D., P.A. d/b/a Dental
Visions, a Florida corporation ("Dental Vision") for a purchase price of
$283,241.
DENTAL PRACTICE
The Company, in addition to sales and marketing of the "areas of
exclusivity", manages a dental practice in Coral Springs, Florida where its
subsidiary, UDC, utilizes the services of 17 individuals pursuant to a
management agreement with Dr. George D. Green, DDS, P.A. The Coral Springs
office is comprised of two licensed dentists, a licensed associate dentist, two
hygienists, four nurses, two office managers, a union dental insurance
specialist, a union dental administrative director and four managerial staff
members.
ACQUISITION OF ADDITIONAL PRACTICES
We intend to acquire existing dental practices in selected geographical
areas throughout the United States to further expand our base of operations by
providing additional locations for the benefit of union members. This expansion
will be accomplished by having the licensed dentist train at the corporate
headquarters prior to being placed into the newly acquired dental practices.
After a period of time the dentist will be evaluated in his/her management
skills and operating procedures. At that time, we intend to allow these dentists
to purchase the existing dental practice from us, after the completion of a
transition period. We intend to finance the acquired business when it is sold to
the new dentist. We believe this will allow us to expand our network of
exclusive areas in a timely manner.
MARKETING AND SALES
BROCHURES AND POSTERS
The union itself is a viable component of our marketing strategy. We
anticipate that the respective unions will be extremely helpful with promoting
the dental benefits provided to their members. Currently, although we pay all
the costs associated with the printing, distribution and mailing of the
brochures, the individual unions are responsible for mailing all pamphlets and
other literature designed and produced by us. We will also design and distribute
8
poster boards to be placed in heavily frequented areas within the employer's
offices, factories or lunchrooms. These poster boards contain brochures which
provide information about the union's dental coverage and list the Dental
Network members in their respective geographical area. We pay for the printing
and mailing of the brochures and poster boards.
SEMINARS
During 2005 we held four seminars where prospective Network members could
learn about us and the benefits of Dental Network membership. Prospective
members also had the opportunity to meet with current network members and other
prospective members. We believe that this is a cost-effective way to recruit
prospective Network members and will continue to sponsor these seminars in 2006.
WEB SITE DEVELOPMENT
We developed a website for use in the expansion of our Dental Network. Our
website will be used as an informative site, and dental directory, for union
patients who are in need of the services offered by the dentists in the network
and to locate a network dentist. The website provides patients with information
about each member of the Dental Network to better inform the patient of the
doctor's professional credentials. The web site will also be used to establish a
direct link between the patient and the doctor. We believe this approach will
enhance the dentist-patient relationship, improve patient loyalty, and increase
utilization of dental services. We have two websites located at
www.uniondental.com and www.uniondentalcorp.com respectively. To date, several
unions have hyperlinked their website to our website in order to avail their
members more access to the dental benefits offered to them and current
information of dental providers in the network.
We presently derive our sales from the following: (1) sales of the "Areas
of Exclusivity" in the selected geographical areas to dentists who provide
dental services to the union employees in those specific areas; and (2)
operating a dental practice at its corporate headquarters located in Coral
Springs, Florida.
COMPETITIVE BUSINESS CONDITIONS
The fields of dental practice and dental network participation with unions
are highly competitive. We compete with a number of businesses that provide the
same or similar services. Many of these competitors have a longer operating
history, greater financial resources, and provide other services to insurance
companies that we do not provide. Principal competitors include national firms,
as well as many regional firms. We believe that quality of service, high caliber
dental services, proper pricing and range of services offered are the principal
factors that will enable us to compete effectively.
GOVERNMENT REGULATIONS
As a participant in the health care industry, our operations are subject to
extensive and increasing regulation by a number of governmental entities at the
federal, state and local levels. We also are subject to laws and regulations
relating to business corporations in general. The Company believes its
operations are in material compliance with applicable laws and will be able to
maintain compliant in an ever increasing regulatory environment.
9
Costs and Effects of Compliance with Environmental Laws.
Some of the services provided by the Company will produce byproducts or
waste, the disposal of which is regulated by Federal or State guidelines. The
Company is aware of the requirements of these regulating agencies and has taken
steps to ensure compliance with the legal requirements.
EMPLOYEES
Except for Dr. Green, the Company's chief executive officer, the Company
does not have any employees. However, the Company utilizes the services of
seventeen (17) individuals that are employed through UDC, as a management
company, to Dr. George D. Green, DDS, P.A. We anticipate hiring either directly
or through the management company additional employees over the next twelve
months if we are successful in implementing our plan of operations.
AVAILABLE INFORMATION
Information regarding the Company's annual reports on Form 10-KSB,
quarterly reports on Form 10-QSB, current reports on Form 8-K, and any
amendments to these reports, are available to the public from the SEC's website
at http://www.sec.gov as soon as reasonably practicable after the Company
electronically files such reports with the Securities and Exchange Commission.
Any document that the Company files with the SEC may also be read and copied at
the SEC's public reference room located at Room 1024, Judiciary Plaza, 450 Fifth
Street, N.W., Washington, DC 20549. Please call the SEC at 1-800-SEC-0330 for
further information on the public reference room. We will also supply this
information to any shareholder requesting copies of any of the foregoing free of
charge. Shareholders should contact our office at (954) 575-2252 if they desire
copies of any of our filings with the Securities and Exchange Commission.
RISK FACTORS
You should consider each of the following risk factors and any other
information set forth in this Form 10-KSB and the other Company's reports filed
with the Securities and Exchange Commission ("SEC"), including the Company's
financial statements and related notes, in evaluating the Company's business and
prospects. The risks and uncertainties described below are not the only ones
that impact on the Company's operations and business. Additional risks and
uncertainties not presently known to the Company, or that the Company currently
considers immaterial, may also impair its business or operations. If any of the
following risks actually occur, the Company's business and financial condition,
results or prospects could be harmed.
RISKS ASSOCIATED WITH THE COMPANY'S PROSPECTIVE BUSINESS AND OPERATIONS
The Company lacks meaningful operating history and will require substantial
capital if it is to be successful. The Company has a limited operating history
in connection with its network provider business ("DDS") upon which an
evaluation of its future success or failure can be made. The Company's ability
to achieve and maintain profitability and positive cash flow over time will be
dependent upon, among other things, its ability to (i) identify and execute
exclusive contracts with the unions and (ii) raise the necessary capital to
operate during this period. At this stage in the Company's development, it
cannot be predicted how much financing will be required to accomplish its
objectives.
10
Our auditors have issued a going concern opinion based on our financial
situation as of December 31, 2005. We have accumulated losses from operations
totaling $1,612,178, a working capital deficit of $1,294,563 and a stockholders'
deficit of $1,808,384. If we are not able to continue as a going concern, you
will likely lose your entire investment.
The Company needs to raise substantial funds in order to implement its
business plan in the foreseeable future. The Company presently does not have
sufficient revenues nor profits required to acquire dental practices and to
expand its network provider businesses. No assurances can be given that the
Company will be able to obtain the necessary funding during this time to make
their acquisitions and expansions. The inability to raise additional funds will
have a material adverse affect on the Company's business, plan of operation and
prospects. The Company's success is dependent upon a limited number of people.
The ability to implement the Company's business plan is dependent upon the
efforts of its President, Dr. George D. Green. The loss of his services could
have a material adverse affect on the Company. The Company's business will be
harmed if it is unable to manage growth.
The Company's business may experience periods of rapid growth that will
place significant demands on its managerial, operational and financial
resources. In order to manage this possible growth, the Company must continue to
improve and expand its management, operational and financial systems and
controls. The Company will need to expand, train and manage its employee base.
No assurances can be given that the Company will be able to timely and
effectively meet such demands. The issuance of shares through our stock
compensation and incentive plans may dilute the value of existing shareholders.
We have used and anticipate continuing to use stock options, stock grants
and other equity-based incentives, to provide motivation and compensation to our
officers, employees and key independent consultants. The award of any such
incentives will result in an immediate and potentially substantial dilution to
our existing shareholders and could result in a decline in the value of our
stock price.
We have financed part of our growth over the past year through an equity
line of credit and the sale of convertible debt instruments. The use of these
financing tools will result in further dilution to our existing shareholders and
could result in the decline in the value of our common stock.
We have not voluntarily implemented various corporate governance measures
in the absence of which, shareholders may have more limited protections against
interested director transactions, conflicts of interest and similar matters.
Recent Federal legislation, including the Sarbanes-Oxley Act of 2002, has
resulted in the adoption of various corporate governance measures designed to
promote the integrity of the corporate management and the securities markets.
Some of these measures have been adopted in response to legal requirements.
Others have been adopted by companies in response to the requirements of
national securities exchanges, such as the NYSE or The Nasdaq Stock Market, on
which their securities are listed. Among the corporate governance measures that
are required under the rules of national securities exchanges and Nasdaq are
those that address board of directors' independence, audit committee oversight,
11
and the adoption of a code of ethics. While our board of directors has adopted a
Code of Ethics and Business Conduct, we have not yet adopted any of these other
corporate governance measures and, since our securities are not yet listed on a
national securities exchange or Nasdaq, we are not required to do so. It is
possible that if we were to adopt some or all of these corporate governance
measures, shareholders would benefit from somewhat greater assurances that
internal corporate decisions were being made by disinterested directors and that
policies had been implemented to define responsible conduct. For example, in the
absence of audit, nominating and compensation committees comprised of at least a
majority of independent directors, decisions concerning matters such as
compensation packages to our senior officers and recommendations for director
nominees may be made by a majority of directors who have an interest in the
outcome of the matters being decided. Prospective investors should bear in mind
our current lack of corporate governance measures in formulating their
investment decisions.
Provisions of our Articles of Incorporation and Bylaws may delay or prevent
take-over, which may not be in the best interest of our stockholders.
Provisions of our articles of incorporation and bylaws may be deemed to
have anti-takeover effects, which include when and by whom special meetings of
our stockholders may be called, and may delay, defer or prevent a takeover
attempt. In addition, certain provisions of the Florida Statutes also may be
deemed to have certain anti-takeover effects , which include that control of
shares acquired in excess of certain specified thresholds will not possess any
voting rights unless these voting rights are approved by a majority of a
corporation's disinterested stockholders. In addition, our articles of
incorporation authorize the issuance of up to 25,000,000 shares of preferred
stock with such rights and preferences as may be determined from time to time by
our board of directors, of which 1,000,000 shares of Class A Preferred Stock are
issued and outstanding as of March 1, 2006. Each share of Class A Preferred
shall have 15 votes per share. Our board of directors may, without stockholder
approval, issue preferred stock with dividends, liquidation, conversion, voting
or other rights that could adversely affect the voting power or other rights of
the holders of our common stock.
We may be exposed to potential risks relating to our internal controls over
financial reporting and our ability to have those controls attested to by our
independent auditors.
As directed by Section 404 of the Sarbanes-Oxley Act of 2002 ("SOX 404"),
the Securities and Exchange Commission adopted rules requiring public companies
to include a report of management on the company's internal controls over
financial reporting in their annual reports, including Form 10-KSB. In addition,
the independent registered public accounting firm auditing a company's financial
statements must also attest to and report on management's assessment of the
effectiveness of the company's internal controls over financial reporting as
well as the operating effectiveness of the company's internal controls. We were
not subject to these requirements for the fiscal year ended December 31, 2004.
We are evaluating our internal control systems in order to allow our management
to report on, and our independent auditors attest to, our internal controls, as
a required part of our Annual Report on Form 10-KSB beginning with our report
for the fiscal year ended December 31, 2006.
12
While we expect to expend significant resources in developing the necessary
documentation and testing procedures required by SOX 404, there is a risk that
we will not comply with all of the requirements imposed thereby. At present,
there is no precedent available with which to measure compliance adequacy.
Accordingly, there can be no positive assurance that we will receive a positive
attestation from our independent auditors. In the event we identify significant
deficiencies or material weaknesses in our internal controls that we cannot
remediate in a timely manner or we are unable to receive a positive attestation
from our independent auditors with respect to our internal controls, investors
and others may lose confidence in the reliability of our financial statements
and our ability to obtain equity or debt financing could suffer.
Risks Related to the Company's Common Stock
The Company does not expect to pay dividends in the foreseeable future.
The Company has never paid cash dividends on its common stock and has no
plans to do so in the foreseeable future. The Company intends to retain
earnings, if any, to develop and expand its business.
"Penny stock" rules may make buying or selling the common stock difficult and
severely limit their market and liquidity.
Trading in the Company's common stock is subject to certain regulations
adopted by the SEC commonly known as the "Penny Stock Rules". The Company's
common stock qualifies as penny stock and is covered by Section 15(g) of the
Securities and Exchange Act of 1934, as amended (the "1934 Act"), which imposes
additional sales practice requirements on broker/dealers who sell the Company's
common stock in the market. The "Penny Stock" rules govern how broker/dealers
can deal with their clients and "penny stock". For sales of the Company's common
stock, the broker/dealer must make a special suitability determination and
receive from clients a written agreement prior to making a sale. The additional
burdens imposed upon broker/dealers by the "penny stock" rules may discourage
broker/dealers from effecting transactions in the Company's common stock, which
could severely limit its market price and liquidity. This could prevent
investors from reselling our common stock and may cause the price of the common
stock to decline.
Although publicly traded, the Company's common stock has substantially less
liquidity than the average trading market for a stock quoted on other national
exchanges, and our price may fluctuate dramatically in the future.
Although the Company's common stock is listed for trading on the
Over-the-Counter Electronic Bulletin Board, the trading market in the common
stock has substantially less liquidity than the average trading market for
companies quoted on other national stock exchanges and our price may fluctuate
dramatically. A public trading market having the desired characteristics of
depth, liquidity and orderliness depends on the presence in the marketplace of
willing buyers and sellers of our common stock at any given time. This presence
depends on the individual decisions of investors and general economic and market
conditions over which we have no control. Due to limited trading volume, the
market price of the Company's common stock may fluctuate significantly in the
future, and these fluctuations may be unrelated to the Company's performance.
General market price declines or overall market volatility in the future could
adversely affect the price of the Company's common stock, and the current market
price may not be indicative of future market prices.
13
Our stock price may be volatile
The market price of our common stock is likely to be highly volatile and
could fluctuate widely in price in response to various factors, many of which
are beyond our control, including:
o technological innovations or new products and services by us or our
competitors;
o additions or departures of key personnel;
o sales of our common stock
o our ability to integrate operations, technology, products and services;
o our ability to execute our business plan;
o operating results below expectations;
o loss of any strategic relationship;
o industry developments;
o economic and other external factors; and
o period-to-period fluctuations in our financial results.
Because we have a limited operating history with our Direct Dental
Services, business, you may consider any one of these factors to be material.
Our stock price may fluctuate widely as a result of any of the above listed
factors.
In addition, the securities markets have from time to time experienced
significant price and volume fluctuations that are unrelated to the operating
performance of particular companies. These market fluctuations may also
materially and adversely affect the market price of our common stock.
Risks relating to the Debenture Agreement:
Dutchess, the holder of a Convertible Debenture issued by us on August 17,
2005 has the option of converting the Debenture into shares of our common stock.
Dutchess may also exercise their common stock purchase options. If the Debenture
is converted or the warrants exercised, there will be dilution of your shares of
our common stock.
The issuance of shares of our common stock upon conversion of the Debenture
will result in the dilution to the interests of other holders of our common
stock, since Dutchess may sell all of the resulting shares into the public
market.
The principal amount of the Debenture plus accrued interest may be
converted at the option of the Dutchess into shares of our common stock at a
conversion price equal to $.092.
Sales of a substantial number of shares of our common stock into the public
market by the holder of our Convertible Debenture may result in significant
downward pressure on the price of our common stock and could affect the ability
of our stockholders to realize the current trading price of our stock.
As we draw down the equity line of credit and we issue common stock to
Dutchess, such common stock will be purchased by Dutchess at less than the then
market price. At such times, Dutchess will have a financial incentive to sell
our common stock immediately upon receiving the shares. When Dutchess sells
shares of our common stock, the price of our stock could decrease. If our stock
14
price decreases, Dutchess may have a further incentive to sell the shares of our
common stock that it holds. Such sales of common stock by Dutchess could cause
the market price of our common stock to decline.
If Dutchess converts the Convertible Debenture and any accrued interest,
Dutchess may acquire and resell up to 8,857,396 shares of our common stock. The
issuance of the shares of our common stock upon conversion of the convertible
Debenture will result in dilution to the interests of the other holders of our
common stock. The resale of our common stock will increase the number of
publicly traded shares which could depress the market price of our common stock
and thereby affect the ability of our shareholders to realize the current price
of our common stock. In addition, as all of the shares we issue to Dutchess will
be available for resale, the mere prospect of our sales to them could depress
the market price of our common stock.
We are also obligated to repay Dutchess the sum of $960,000 pursuant to a
one year promissory note dated December 22, 2005. Repayment of this debt will
likely result in the issuance of additional shares of common stock which will
cause further dilution. Moreover, since we will be required to allocate a
portion of each Put from our equity credit line to repay this obligation, our
ability to secure additional capital will be restricted.
Risks relating to the Investment Agreement:
There are a large number of shares underlying our periodic equity
investment agreement with Dutchess. The issuance and sale of shares upon
delivery of an advance by Dutchess Private Equities Fund II, LP ("Dutchess")
pursuant to the Investment Agreement in the amount up to $5,000,000 and the
conversion of the Debenture and exercise of options by Dutchess are likely to
result in substantial dilution to the interests of other stockholders. Up to
38,461,538 are reserved for issuance pursuant to the Investment Agreement with
Dutchess Private Equities Fund II, LP. Assuming the issuance of 38,461,538
shares under the Investment Agreement, existing shareholders will experience
substantial dilution of our shares of Common Stock.
Our Investment Agreement with Dutchess contemplates the potential future
issuance and sales of up to $5,000,000 of our Common Stock to Dutchess subject
to certain restrictions and obligations. Given out current capital needs and the
market price of our common stock, we presently have no intention of drawing down
the entire amount available to us unless the market price of our common stock
increases.
The large number of shares issuable under the Investment Agreement may
result in a change of control.
If we were request the maximum of $5,000,000 pursuant to the Investment
Agreement, assuming a conversion price of $.13 (which is greater than our
current trading price) we would issue to Dutchess 38,461,538 shares of our
common stock. This would result in Dutchess controlling us. Dutchess may be able
to exert substantial influence over all matters submitted to a vote of the
shareholders, including the election and removal of directors, amendments to our
articles of incorporation and by-laws, and the approval of a merger,
consolidation or sale of all or substantially all of our assets. In addition,
15
this concentration of ownership could inhibit the management of our business and
affairs and have the effect of delaying, deferring or preventing a change in
control or impeding a merger, consolidation, takeover or other business
combination which our shareholders, may view unfavorably.
The lower the stock price, the greater the number of shares issuable under the
Investment Agreement.
The number of shares that Dutchess will receive under its agreement with us
is calculated based upon the market price of our common stock prevailing at the
time of each "put". The lower the market price, the greater the number of shares
issuable under the agreement. Upon issuance of the shares, to the extent that
Dutchess will attempt to sell the shares into the market, these sales may
further reduce the market price of our common stock. This in turn will increase
the number of shares issuable under the agreement. This may lead to an
escalation of lower market prices and ever greater numbers of shares to be
issued. A larger number of shares issuable at a discount to a continuously
declining stock price will expose our shareholders to greater dilution and a
reduction of the value of their investment.
The sale of our stock under the Dutchess agreement could encourage short
sales by third parties, which could contribute to the future decline of our
stock price and materially dilute existing stockholders' equity and voting
rights.
Neither the Investment Agreement nor the Debenture Agreement contain
restrictions on short selling. Accordingly, any significant downward pressure on
the price of our common stock can encourage short sales by them or others,
subject to applicable securities laws. This is particularly the case if the
shares being placed into the market exceed the market's ability to absorb the
increased number of shares of stock or if we have not performed in such a manner
to show that the equity funds raised will be used by us to grow. Such an event
could place further downward pressure on the price of our common stock. Even if
we use the proceeds under the agreement to grow our revenues and profits or
invest in assets, which are materially beneficial to us, the opportunity exists
for short sellers and others to contribute to the future decline of our stock
price. If there are significant short sales of our stock, the price decline that
would result from this activity will cause the share price to decline more so,
which, in turn, may cause long holders of the stock to sell their shares thereby
contributing to sales of stock in the market. If there is an imbalance on the
sell side of the market for the stock, our stock price will decline. If this
occurs, the number of shares of our common stock that is issuable pursuant to
the Investment Agreement will increase, which will materially dilute existing
stockholders' equity and voting rights.
Item 2. Description of Property
Our offices are located at 1700 University Drive, Coral Springs, Florida
33071. We have leased suite 200 since 1997. Suite 200 consists of approximately
2,200 square feet of professional dental practice space. The lease expires in
April 2006 and we are in negotiations to extend the lease term. Our current
monthly rent for suite 200 inclusive of sales tax and common area maintenance is
16
approximately $4,347 per month. With the acquisition of the dental practice of
Dora Vilk-Shapiro M.D., P.A. we assumed the leasehold obligation for suite 202
at a cost of approximately $2,200 per month inclusive of sales tax and common
area operating expenses. We also lease on a month to month basis suite 304 which
is utilized as an administrative office. We pay a monthly rent of $1,643 plus
common area operating expenses. We believe that the foregoing space is adequate
to meet our current and planned operations.
Item 3. Legal Proceedings
During the second quarter of 2005, Direct Dental was sued by a former
member of our network. The suit alleges that the company breached the
exclusivity provisions of its agreement with Direct Dental by selling the
territory to another dentist. The lawsuit was filed in Dade County, Florida
(Case No. 05-08811 CA 2). Management believes that it has a meritorious defense
to this action in that the territory was only sold after the plaintiff failed to
make the required payments due under the management agreement to remain part of
our network.
During the second quarter of 2005 we were sued by another dentist who was
previously a Direct Dental member. The suit was filed in Dade County, Florida
(Case No. 05-0077-99) and alleges tortuous interference with a business
relationship and libel. Management believes that it has meritorious defenses in
that this action was brought in response to a lawsuit filed by the company
against the same dentist for breach of contract, slander, tortuous interference
with a business relationship and injunctive relief (Case No. 04-12109 CA 10). We
filed this action when the dentist failed to pay the required fee to remain a
member of the Direct Dental network and attempted to create his own network of
service providers.
Item 4. Submission of Matters to a Vote of Security Holders
No matter was submitted to a vote of our shareholders, through the
solicitation of proxies or otherwise during the fourth quarter of our fiscal
year ended December 31, 2005, covered by this report.
PART II
Item 5. Market for Common Equity and Related Stockholder Matters.
a) Market Information. The Company's common stock began trading on the
Over-the-Counter Bulletin Board (the "OTCBB") on October 6, 2004. Our current
stock symbol is "UDHI.OB". The following table sets forth, for the periods
indicated, the range of high and low bid quotations for our common stock as
quoted on the OTCBB. The reported bid quotations reflect inter-dealer prices
without retail markup, markdown or commissions, and may not necessarily
represent actual transactions. Prices set forth below have been adjusted to give
effect to the one for forty reverse stock split which was approved by the
stockholders on May 10, 2004.
17
Year 2003- There was no market for our common stock.
Year 2004 High Low
------------------- ------ -----
First Quarter $.00 $.00
Second Quarter .01 .01
Third Quarter .02 .01
Fourth Quarter .55 .02
Year 2005 High Low
------------------- ------ -----
First Quarter $.74 $.17
Second Quarter .20 .11
Third Quarter .22 .09
Fourth Quarter .15 .09
Year 2006 High Low
------------------- ------ -----
Through March 16, $.12 $.08
Such market quotations reflect the high bid and low prices as reflected by
the OTCBB or by prices, without retail mark-up, markdown or commissions and may
not necessarily represent actual transactions. Some of the companies who serve
as market makers for our common stock include WM. V. Frankel & Co., Hill
Thompson Magid & Co, Knight Equity Markets, L.P. and Schwab Capital Markets L.P.
Our shares are subject to the provisions of Section 15(g) and Rule 15g-9 of the
Securities Exchange Act of 1934, as amended (the Exchange Act"), commonly
referred to as the "penny stock" rule. Section 15(g) sets forth certain
requirements for transactions in penny stocks and Rule 15g9(d)(1) incorporates
the definition of penny stock as that used in Rule 3a51-1 of the Exchange Act.
The Commission generally defines penny stock to be any equity security that
has a market price less than $5.00 per share, subject to certain exceptions.
Rule 3a51-1 provides that any equity security is considered to be penny stock
unless that security is: registered and traded on a national securities exchange
meeting specified criteria set by the Commission; authorized for quotation on
The NASDAQ Stock Market; issued by a registered investment company; excluded
from the definition on the basis of price (at least $5.00 persuade) or the
registrant's net tangible assets; or exempted from the definition by the
Commission. Since our shares are deemed to be "penny stocks", trading in the
shares will be subject to additional sales practice requirements on
broker-dealers who sell penny stocks to persons other than established customers
and accredited investors.
For transactions covered by these rules, broker-dealers must make a special
suitability determination for the purchase of such securities and must have
received the purchaser's written consent to the transaction prior to the
purchase. Additionally, for any transaction involving a penny stock, unless
exempt, the rules require the delivery, prior to the first transaction, of a
risk disclosure document relating to the penny stock market. A broker-dealer
also must disclose the commissions payable to both the broker-dealer and the
registered representative, and current quotations for the securities. Finally,
the monthly statements must be sent disclosing recent price information for the
18
penny stocks held in the account and information on the limited market in penny
stocks. Consequently, these rules may restrict the ability of broker dealers to
trade and/or maintain a market in our Common Stock and may affect the ability of
shareholders to sell their shares.
Transfer Agent
Our transfer agent is Interwest Transfer Co., Inc., 1981 East Murray
Holiday Road, Suite 100, Salt Lake City, UT 84117. Their telephone number is
(801) 272-9294.
(b) Holders. As of March 1, 2006, there were 426 shareholders of record of
our common stock.
(c) Dividend Policy. We have not declared or paid cash dividends or made
distributions in the past, and we do not anticipate that we will pay cash
dividends or make distributions in the foreseeable future. We currently intend
to retain and reinvest future earnings, if any, to finance our operations.
(d) Securities authorized for issuance under equity compensation plans
The following table sets forth all securities which we may issue under any
equity compensation plan.h
Equity Compensation Plan Information
Number of securities to Weighted average
be issued upon exercise exercise price of Number of securities
of outstanding options, outstanding options, remaining available for
Plan category warrants and rights warrants and rights future issuance
(a) (b) (c)
===================================== ======================= ==================== =======================
Equity compensation plans approved
by security holders (1)(3) 1,508,000 $0.16 6,792,000
Equity compensation plans no
approved by security holders (2) -0- $-0- -0-
Total
(1)Effective December 30, 2006, we reached agreement with several holders
of our outstanding options whereby we cancelled 1.5 million options at exercise
prices varying between $.50 and $.60 per share and issued a total of 950,000
options at prices ranging from $.13 to $.15 per share. At the time of the grant
of the options, the closing bid price of the Company's common stock was $.10 per
share. All of the outstanding options were cancelled, and new options were
issued at a lower exercise price.
19
(2)Includes 1,304,348 warrants which may be exerecised at a price of $.092
per share issued to Dutchess Private Equities Fund II, L.P. and 500,000 warrants
which may be exercised at a price of $.20 per share issued to Hawk Associates.
Both Dutchess options and the Hawk warrants and the underlying shares were
registered as part of our SB-2 registration statement filed with the Securities
and Exchange Commission on September 9, 2005.
(3) Does not include a total of 1,245,000 performance based options of
which 997,500 have been granted to George Green and 247,500 granted to a
consultant.
Recent Sales of Unregistered Securities.
During February 2004, we issued 1 million shares of our common stock
(250,000 post split) to a group of investors for $25,000 cash. The sale of the
securities was exempt from registration under Section 4(2)of the Securities Act
of 1933, as amended. The transaction did not include a public distribution or
offering.
During April 2004 through December 2004, we conducted a private placement
offering of our securities whereby we received proceeds in the amount of
$417,006 pursuant to promissory notes that were subsequently converted into
913,939 shares of our restricted common stock. The debt was converted into our
common stock at $.50 per share as of the Reorganization and such conversion
included accrued interest of $39,963. This transaction was exempt from
registration claimed under section 4(2) of the Securities Act of 1933, as
amended, and Rule 506 of Regulation D promulgated thereunder. The shares were
sold through the company's officers and directors to a total of 21 investors.
The transaction did not include a public distribution or offering.
During July 2004, UDC agreed to issue 100,000 shares of its common stock to
The Bulletin Board Productions, LLC in exchange for consulting services that
included video production and advertising services valued at $10,500 plus total
production and media costs of $39,500, representing an aggregate value of
$50,000. On the transaction date, UDC's common stock had no reliable market
value. UDC valued the shares issued by the value of the marketing expenditure at
$.50 per share. As a result, the Company recognized a stock-based compensation
expense totaling $50,000 in the accompanying financial statements. The
transaction was exempt from registration under Section 4(2) as the recipient of
the shares is a sophisticated investor and was provided with access to the
officers of UDC so as to receive all material information regarding UDC that the
recipient requested. The shares were issued with restrictive legend and the
transactions did not include a public distribution or offering.
During October 2004, the Company issued 18,800,000 shares of its common
stock to Roger Pawson for services rendered as our former sole officer and
director. As a result, the Company recognized a stock-based compensation expense
totaling $18,800 in the accompanying financial statements. The transaction was
exempt from registration under Section 4(2) as the recipient of the shares is a
sophisticated investor. The shares were issued with restrictive legend and the
transactions did not include a public distribution or offering. These shares
were subsequently cancelled as part of the Reorganization.
20
During October 2004, the Company issued 10,000,000 shares of its common
stock to various note holders upon the conversion of convertible notes payable
in the amount of $27,500. This transaction was exempt from registration claimed
under section 4(2) of the Securities Act of 1933, as amended, and Rule 506 of
Regulation D promulgated thereunder. The shares were sold through the company's
officers and directors. The transaction did not include a public distribution or
offering.
On December 27, 2004 we issued 17,500,000 shares of our common stock and
one million shares of our preferred stock pursuant to a Share Exchange and
Reorganization Agreement to our principal shareholder, Dr. George Green.
During the year 2005 we issued 55,000 shares of unregistered common stock
to various consultants, in consideration for services rendered.
Also, during 2005, we issued a total of 120,000 shares of our common stock
to various investors in consideration for a total of $60,000.
On August 17, 2005 we sold $600,000 in principal amount of our five-year
convertible debentures to Dutchess These debentures bear interest at 10% per
annum (payable in cash or stock at Dutchess' option). The conversion price of
these debentures is $.092 per share. The shares to be issued pursuant to this
convertible debenture were subsequently registered with the Securities and
Exchange Commission.
On December 22, 2005, the Company signed a promissory note (the "Note") in
favor of Dutchess Private Equities Fund, LP (the "Investor"), in the amount of
$960,000 (the "Face Amount") and received gross proceeds in the amount of
$800,000 less $60,075 in fees associated with the financing for net proceeds of
$739,925. The Company is obligated to repay the Investor the Face Amount on or
before December 23, 2006. Payments are to be made by the Company from each Put
from the Company's Equity Credit Line.
The securities issued in the foregoing transactions were made in reliance
upon an exemption from registration under Rule 701 promulgated under Section
3(b) of the Securities Act and or Section 4(2) of the Securities Act.
Alternatively, these issuances of securities were undertaken under Rule 506 of
Regulation D under the Securities Act of 1933, as amended, by the fact that:
- the sale was made to a sophisticated or accredited investor, as defined in
Rule 502;
- we gave the purchaser the opportunity to ask questions and receive answers
concerning the terms and conditions of the offering and to obtain any
additional information which we possessed or could acquire without
unreasonable effort or expense that is necessary to verify the accuracy of
information furnished;
- at a reasonable time prior to the sale of securities, we advised the
purchaser of the limitations on resale in the manner contained in Rule
502(d)2; and
- neither we nor any person acting on our behalf sold the securities by any
form of general solicitation or general advertising; and
21
Use of Proceeds from sale of Registered Securities
During the fiscal year ended December 31, 2005, we received approximately
$600,000 net of fees and expenses from the sale of our registered securities. We
received approximately $541,000 (net of expenses) from the sale of our
convertible debentures. We received approximately $59,000 when Dutchess
converted a portion of the convertible debenture into shares of our common stock
at a conversion price of $.092 per share. We used the proceeds from the sale of
these registered securities for general working capital purposes.
We also issued a total of 1.2 million shares of our registered common stock
to various consultants for services rendered.
Item 6. Management's Discussion and Analysis
Operations
This report on Form 10-KSB contains forward-looking statements that are
subject to risks and uncertainties that could cause actual results to differ
materially from those discussed in the forward-looking statements and from
historical results of operations. Among the risks and uncertainties which could
cause such a difference are those relating to our dependence upon certain key
personnel, our ability to manage our growth, our success in implementing the
business strategy, our success in arranging financing where required, and the
risk of economic and market factors affecting our customers or us. Many of such
risk factors are beyond the control of the Company and its management.
Plan of Operations
We operate our business through our two wholly owned subsidiaries, Direct
Dental Services, Inc. ("DDS") and Union Dental Corp. ("UDC"). DDS operates a
network of duly licensed dental providers. Members of the dental network pay an
annual management service fee for the right to be a member of the dental
network. UDC operates a dental practice in Coral Springs, Florida. The Company
intends to expand its network of dental providers. The Company may also expand
and offer participating unions other professional services such as chiropractic
and optometrists. The Company may also acquire additional dental practices which
the Company believes application of its Dental Practice Management Model will
improve operating performance.
Management's current focus is the expansion of its dental network. We
intend to expand in existing markets primarily by enhancing the operating
performance of our existing office, by acquiring dental practices, by adding
union contracts in states where we currently do not have union contracts and by
developing dental network union contracts with other unions. At this time it is
not possible to project what income or expenses will result from the expansion
of these services.
In order to finance our operations, growth and expansion, on August 17,
2005, we entered into an Investment Agreement with Dutchess Private Equity Fund
II, LLP ("Dutchess"). Pursuant to this Agreement, Dutchess will commit to
purchase up to $5,000,000 of our Common Stock over the course of 36 months,
22
beginning September 15, 2005, the date our registration statement was declared
effective by the SEC. Under the agreement, we may sell to Dutchess on each
occasion, either (1) $100,000 in shares of our common stock or (2) 200% of the
averaged daily volume (U.S market only) of our Common Stock for the 20 trading
days prior to our "Put" notice, multiplied by the average of the 3 daily closing
prices immediately preceding the Put Date. The Market Price shall be the lowest
closing bid price of our common stock during the Pricing Period. The Purchase
Price shall be set at 95% of the Market Price. This Investment Agreement
establishes what is sometimes termed an equity line of credit or an equity
drawdown facility.
In general, the drawdown facility operates as follows: Dutchess, has
committed to provide us with up to $5,000,000 as we request over a 36 month
period, in return for common stock that we issue to Dutchess. We may, in our
sole discretion, during the Open Period deliver a "put notice" (the "Put
Notice") to Duchess which states the dollar amount which we intend to sell to
Dutchess on the Closing Date. The Open Period is the period beginning on the
trading after the Effective Date and which ends on the earlier to occur of 36
months from the Effective Date or termination of the Investment Agreement in
accordance with its terms. The Closing Date shall mean no more than 7 trading
days following the Put Notice Date. The Put Notice Date shall mean the Trading
Day immediately following the day on which Dutchess receives a Put Notice, as
defined in the agreement.
During the Open Period, we are not entitled to submit a Put Notice until
after the previous Closing has been completed.
Upon the receipt by Dutchess of a validly delivered Put Notice, Dutchess
shall be required to purchase from us, during the period beginning on the Put
Notice Date and ending on and including the date that is 5 trading days after
such Put Notice, that number of shares having an aggregate purchase price equal
to the lesser of (a) the Put Amount set forth in the Put Notice, or (b) 20% of
the aggregate trading volume of our common stock during the applicable Pricing
Period times (x) the lowest closing bid price of our common stock during the
specified Pricing period, but only if such said shares bear no restrictive
legend and are not subject to stop transfer instructions, prior to the
applicable Closing Date.
As a result of this variable price feature, the number of shares issuable
pursuant to the agreement will increase if the market price of our stock
decreases. In addition there is no upper limited on the number of shares
issuable pursuant to the agreement. Therefore our shareholders may be subject to
significant dilution and face the prospect of a change in control. (See Footnote
4 to our Financial Statements).
As of December 31, 2005, the Company had not delivered any Put Notices and
has not drawn on the equity line of credit.
If for some reason we are not able to draw down the entire $5,000,000, for
example if the price of our common stock does not increase, we may have to
obtain additional operating capital from other sources to enable us to execute
our business plan. We anticipate that we will obtain any additional required
23
working capital through the private placement of Common Stock to domestic
accredited investors pursuant to Regulation D of the Securities Act of 1933, as
amended. There is no assurance that we will obtain the additional working
capital that we need through the private placement of Common Stock. In addition,
such financing may not be available in sufficient amounts or on terms acceptable
to us.
Also in connection with the Dutchess financing, on August 17, 2005, we
entered into a Debenture Agreement with Dutchess, an accredited investor, for
the issuance and sale of $600,000 of 10% secured convertible debenture due
August 17, 2010 in a private transaction exempt from registration under the
Securities Act of 1933 in reliance on exemptions provided by Section 4(2) and
Regulation D of the Act. At the time of signing the Debenture Agreement, we also
issued Dutchess a five-year common stock purchase warrant to purchase 1,304,348
shares of our common stock at $.092 per share.
Interest is payable on the secured convertible debentures at the rate of
10% per year. Amortizing payments will be made by us in satisfaction of this
Debenture. Payments shall be made monthly on the first day of each business day
of each month while there is an outstanding balance on the Debenture, to the
Holder, in the amounts outlined below on the following schedule:
Payment for Month 1: $4,951
(due within three (3) days of the Issuance Date)
Payment for Month 2: $4,951
Payment for Month 3: $4,951
Payment for Month 4
and each month thereafter: $62,716
The principal amount of the Debenture plus accrued interest may be
converted at the option of Dutchess into shares of our common stock, anytime
following the closing date, at a conversion price equal to the lesser of (i) the
lowest closing bid price during the 15 days of full trading, as defined, prior
to the conversion date; or (ii) $0.092. In addition, in the event that any
portion of the debenture remains outstanding on the maturity date of August 17,
2010, such outstanding amount shall be automatically converted into shares of
our common stock. In the event that we do not make delivery of the common stock
as instructed by Dutchess, we shall be obligated to pay to Dutchess 3% in cash
of the dollar value of the debentures being converted, compounded daily, per
each day after the 3rd business day following the conversion date that the
common stock is not delivered to Dutchess. In the event of default as defined in
the Debenture Agreement, Dutchess may among other things:
(a) elect to secure a portion of the Company's assets not to exceed 200% of
the Face Amount of the Note, in Pledged Collateral; (b) elect to garnish Revenue
from us in an amount that will repay the Holder on the payment schedule set
forth above; (c) exercise its right to increase the Face Amount of the debenture
by ten percent (10%) as an initial penalty and for each Event of Default under
the Debenture; (d) elect to increase the Face Amount by two and one-half percent
(2.5%) per month (pro-rata for partial periods) paid as a penalty for liquated
damages which will be compounded daily;
24
The debenture provides that Dutchess shall not be entitled to convert that
amount of Debenture into common stock, which when added with the sum of the
number of shares beneficially owned by Dutchess would exceed 4.99% of the number
of shares of our common stock outstanding on the conversion date.
In order to secure its obligations under the secured convertible debenture
and related documents, we have granted Dutchess a security interest in all of
our assets and property.
On December 22, 2005, the Company signed a promissory note (the "Note") in
favor of Dutchess in the amount of $960,000 (the "Face Amount") and received
gross proceeds in the amount of $800,000 less $60,075 in fees associated with
the financing for net proceeds of $739,925. The Company is obligated to repay
the Investor the Face Amount on or before December 23, 2006. There is no stated
interest rate on the Note. Payments are to be made by the Company from each Put
from the Company's Equity Credit Line we have with Dutchess. The Company is
obligated to pay Dutchess the greater of a) 50% of each Put to the Investor or
b) $80,000 until the face Amount minus any fees have been paid. The first
payment was due on February 15, 2006 and all subsequent payments will be made at
the Closing of every Put to Dutchess thereafter. The Put Amount will be the
maximum amount allowed under the Investment Agreement with Dutchess. Payments
made by the Company in satisfaction of this Note shall be made from each Put
from the Equity Line of Credit with Dutchess. Additionally, in connection with
this obligation, the Company issued 1,500,000 shares of common stock.
We issued 50 signed Put Notices to Dutchess as collateral. In the event,
that Dutchess uses the collateral in full, we are obligated to immediately
deliver to Dutchess additional Put Sheets as requested. In the event that on the
maturity date we have any remaining amounts unpaid on this Note (the "Residual
Amount"), the Holder can exercise its right to increase the Face Amount by ten
percent (10%) as an initial penalty and an additional 2.5% per month paid, pro
rata for partial periods, compounded daily, as liquated damages ("Liquidated
Damages").
Additionally, in the event of a default as defined in the agreement, the
Holder shall have the right, but not the obligation, to 1) switch the Residual
Amount to a three-year ("Convertible Maturity Date"), interest-bearing
convertible debenture. If the Holder chooses to convert the Residual Amount to a
Convertible Debenture, we shall have 20 business days after notice of the same
(the "Notice of Convertible Debenture") to file a registration statement
covering an amount of shares equal to 300% of the Residual Amount. Such
registration statement shall be declared effective under the Securities Act of
1933, as amended (the "Securities Act"), by the Securities and Exchange
Commission (the "Commission") within 40 business days of the date we file such
Registration Statement. In the event we do not file such registration statement
within 20 business days of the Holder's request, or such registration statement
is not declared by the Commission to be effective under the Securities Act
within the time period described above, the Residual Amount shall increase by
$5,000 per day.
The Holder is entitled to convert the Debenture Residual Amount, plus
accrued interest, anytime following the Convertible Maturity Date, at the lesser
of (i) 50% of the lowest closing bid price during the 15 trading immediately
preceding the Convertible Maturity Date or (ii) 100% of the lowest bid price for
the 20 trading days immediately preceding the Convertible Maturity Date ("Fixed
Conversion Price").
25
We have adopted a code of conduct for the operations of our business. We
believe that this code of conduct will promote our business dealings with the
public in general, govern the activities of our officers and employees with
respect to safeguarding corporate assets and dealing fairly with our
shareholders.
Results of Operations
YEAR ENDED DECEMBER 31, 2005 COMPARED TO YEAR ENDED DECEMBER 31, 2004
Revenues
For the year ended December 31, 2005 as compared to December 31, 2004 we
generated revenue of $2,066,944 as compared to $1,931,570.
Net Income
We incurred a net loss of $1,440,183 for 2005 as compared to net income of
$4,989 in the prior year. The significant decline in net income and resulting
loss is primarily attributable to an increase in salaries and related expenses
from $692,099 to $843,204, an increase in depreciation and amortization from
$9,880 to $39,467, an increase in professional fees from $106,336 to $199,018,
an increase in consulting fees from $92,405 to $373,215, an increase in general
and administrative expenses from $594,570 to $762,057 and an increase in our
interest expense from $40,587 to $521,523.
Inclusive within these expenses are non-cash expenses totaling $283,453.
Specifically, we issued a total of 2,158,646 shares of our common stock as stock
based compensation including $107,975 in legal fees and $130,478 for consulting
services.
Our depreciation expense for the year increased from $9,880 to $39,467 due
primarily to the acquisition of the assets of Dental Vision. Professional fees
increased from $106,336 to $199,018 due primarily to costs incurred with respect
to closing our funding agreements with Dutchess and the filing of a Registration
Statement in connection therewith.
The significant increase in the interest expense is primarily associated
with fees associated with the costs incurred in connection with our loan
obligation with Dutchess and to a lesser extent, an increase in our bank line of
credit with Bank of America.
We recorded a net loss of $0.05 per share in 2005 computed on a basic and
diluted basis as compared to no income ($0.00) per share in 2004.
Compensation
During the year ended December 31, 2005 and 2004, the Company incurred
$843,204 and $692,099 respectively, for salaries. The increase in salaries
relates to adding additional personnel and normal wage increases including
additional staff personnel resulting from the acquisition of the assets of
Dental Visions.
26
General and Administrative expenses/amortization and depreciation
During the year ended December 31, 2005 and 2004, we incurred $762,057 and
$594,570, respectively in general and administrative expenses, and $39,467 and
$9,880 in depreciation expense, respectively. A substantial portion, of the
increase in general and administrative expenses were marketing expenses for DDS.
The increase in our depreciation expense is attributable to the acquisition of
the assets of Dental Vision.
Professional Fees
Professional fees increased from $106,366 to $199,018 of which $107,975
represents non-cash compensation paid to certain professionals in consideration
for services rendered.
Liquidity and Capital Resources
At December 31, 2005, we had cash and accounts receivable totaling
$868,105. We had total current assets of $901,636 and our total assets were
$1,337,549.. Our total current liabilities were $3,349,863 We have a working
capital deficit as of December 31, 2005 of $2,448,227..The significant increase
in our working capital deficit is attributable to the financing we have secured
with Dutchess including the outstanding current portion of a convertible
debenture which we have recorded at $206,491 anda derivative liability totaling
$1,414,593. The derivative liability which we recorded on our books is the
result of the convertibility feature and the registration rights which we have
granted to Dutchess. (See Footnotes 3,4 and 5 of our financial statements). We
are also in default under our lending agreement with Bank of America since we
have failed to maintain certain covenants required under the loan documentation.
As a result, we have designated the entire amount of this liability, $1,268,667
as a short term obligation. We have also recorded a liability for unearned
membership fees totaling $313,374.
To the extent that revenues are insufficient to support ongoing operations,
the Company will have to draw against its equity line of credit. With our stock
price currently trading below the conversion price of $.092 per share, it is
unlikely that Dutchess would convert any portion of the outstanding obligation
at the fixed conversion price. Moreover, we were required to deliver Put notices
to Dutchess to satisfy the terms and conditions of the $960,000 promissory note.
Since we will be drawing down our equity line of credit, we will have to issue
additional shares of our common stock which will cause further dilution and
likely downward pressure on the price of our common stock. If the price of our
Common Stock continues to decline, we will not have registered a sufficient
number of shares of common stock to draw against the equity credit line. Should
this happen, we would likely be in default under these obligations.
Our loan with Bank of America is in default. The loan was established to
finance our ongoing operations and as a result of our agreement in December 2004
to assume the debt obligation of the principal stockholder for a bank loan
utilized to purchase 50% of DDS from its founder and former owner and the
remaining balance owed on the original 50% acquisition. The original note was in
the amount $1,215,000. On May 17, 2005, the Company entered into an Amended and
Restated Promissory Note in the amount of $1,384,000. (See Footnote 6 of our
financial statements.)
27
We have an accumulated deficit of $1,820,108 and a stockholders' deficit of
$2,012,314..
We recorded shareholder transactions in 2005 of $1,489,711. This amount was
originally recorded in 2004 as $1,539,129. This charge was a result of three
related party transactions. First, UDC issued a $1 million note payable to Dr.
Green, our controlling shareholder, as consideration for the purchase of the
assets (minus the client list) of his dental practice, Dr. George D. Green, DDS,
P.A. The Second transaction related to DDS executed a note payable to a bank in
the amount of $1,215,000 to satisfy an outstanding liability of Dr. Green to
purchase shares of DDS prior to the Reorganization. These amounts are offset by
$675,871, representing a note receivable from Dr. Green resulting from the above
transactions, net of other payables. See footnote 7 of our financial statements.
As a result of the foregoing accounting treatment of the various
transactions, Dr. Green will be required to repay a portion of these sums to the
Company. As of the date hereof, no repayment schedule has been established. To
the extent that any sums are due as a result of any reclassification of
goodwill, no payments will be made by Dr. Green.
You are urged to review the accompanying financial statements and financial
footnotes in order to fully understand our financial condition.
CRITICAL ACCOUNTING POLICIES
Use of Estimates: The preparation of financial statements in conformity
with accounting principles generally accepted in the United States of America
requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and
liabilities at the date of the financial statements and the reported amounts of
revenues and expenses during the reporting period. Actual results could differ
materially from those estimates.
Income per share: Basic income per share excludes dilution and is computed
by dividing the income attributable to common shareholders by the
weighted-average number of common shares outstanding for the period. Diluted
income per share reflects the potential dilution that could occur if securities
or other contracts to issue common stock were exercised or converted into common
stock or resulted in the issuance of common stock that shared in the income of
the Company. Diluted income per share is computed by dividing the income
available to common shareholders by the weighted average number of common shares
outstanding for the period and dilutive potential common shares outstanding
unless consideration of such dilutive potential common shares would result in
anti-dilution. Common stock equivalents were not considered in the calculation
of diluted income per share as their effect would have been anti-dilutive for
the period ended December 31, 2005 and 2004.
Critical Accounting Policies
The preparation of financial statements in conformity with generally
accepted accounting principles (GAAP) requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the
reporting period. Actual results may differ from those estimates.
28
Off-Balance Sheet Arrangements
We have not entered into any off-balance sheet arrangements. We do not
anticipate entering into any off-balance sheet arrangements during the next 12
months.
RECENT ACCOUNTING PRONOUNCEMENTS
In April 2005, the Securities and Exchange Commission's Office of the Chief
Accountant and its Division of Corporation Finance has released Staff Accounting
Bulletin (SAB) No.107 to provide guidance regarding the application of FASB
Statement No.123 (revised 2004), Share-Based Payment. Statement No. 123(R)
covers a wide range of share-based compensation arrangements including share
options, restricted share plans, performance-based awards, share appreciation
rights, and employee share purchase plans. SAB 107 provides interpretative
guidance related to the interaction between Statement No. 123R and certain SEC
rules and regulations, as well as the staff's views regarding the valuation of
share-based payment arrangements for public companies. SAB 107 also reminds
public companies of the importance of including disclosures within filings made
with the SEC relating to the accounting for share-based payment transactions,
particularly during the transition to Statement No. 123R.
In May 2005, the Financial Accounting Standards Board ("FASB") issued
Statement of Financial Accounting Standards No. 154, "Accounting Changes and
Error Corrections-a replacement of APB Opinion No. 20 and FASB Statement No. 3"
("SFAS 154"). This Statement replaces APB Opinion No. 20, Accounting Changes,
and FASB Statement No. 3, Reporting Accounting Changes in Interim Financial
Statements, and changes the requirements for the accounting for and reporting of
a change in accounting principle. This Statement applies to all voluntary
changes in accounting principle. It also applies to changes required by an
accounting pronouncement in the unusual instance that the pronouncement does not
include specific transition provisions. When a pronouncement includes specific
transition provisions, those provisions should be followed.
Opinion 20 previously required that most voluntary changes in accounting
principle be recognized by including in net income of the period of the change
the cumulative effect of changing to the new accounting principle. This
Statement requires retrospective application to prior periods' financial
statements of changes in accounting principle, unless it is impracticable to
determine either the period-specific effects or the cumulative effect of the
change. When it is impracticable to determine the period-specific effects of an
accounting change on one or more individual prior periods presented, this
Statement requires that the new accounting principle be applied to the balances
of assets and liabilities as of the beginning of the earliest period for which
retrospective application is practicable and that a corresponding adjustment be
made to the opening balance of retained earnings (or other appropriate
components of equity or net assets in the statement of financial position) for
that period rather than being reported in an income statement. When it is
impracticable to determine the cumulative effect of applying a change in
accounting principle to all prior periods, this Statement requires that the new
accounting principle be applied as if it were adopted prospectively from the
earliest date practicable. This Statement shall be effective for accounting
29
changes and corrections of errors made in fiscal years beginning after December
15, 2005. The Company does not believe that the adoption of SFAS 154 will have a
significant effect on its financial statements.
Other accounting standards that have been issued or proposed by the FASB or
other standards-setting bodies that do not require adoption until a future date
are not expected to have a material impact on the consolidated financial
statements upon adoption.
Item 7. Financial Statements
Our financial statements have been examined to the extent indicated in
their reports by De Meo, Young, McGrath & Company, and have been prepared in
accordance with generally accepted accounting principles and pursuant to
Regulation S-B as promulgated by the Securities and Exchange Commission and are
included herein, on Page F-1 hereof in response to Part F/S of this Form 10-KSB.
Item 8. Changes In and Disagreements with Accountants on Accounting and
Financial Disclosure.
None
ITEM 8A. CONTROLS AND PROCEDURES.
(a) Disclosure Controls and Procedures:
Within 90 days prior to the date of this Report, we carried out an
evaluation, under the supervision and with the participation of our Chief
Executive Officer and Chief Financial Officer (or persons performing similar
functions) of the effectiveness of the design and operation of our disclosure
controls and procedures. Based on this evaluation, our Chief Executive Officer
and Chief Financial Officer (or persons performing similar functions) concluded
that our disclosure controls and procedures are effective in timely alerting
them to material information required to be included in our periodic reports
that are filed with the Securities and Exchange Commission. It should be noted
that the design of any system of controls is based in part upon certain
assumptions about the likelihood of future events, and there can be no assurance
that any design will succeed in achieving its stated goals under all potential
future conditions, regardless of how remote. In addition, we reviewed our
internal controls, and there have been no significant changes in our internal
controls or in other factors that could significantly affect those controls
subsequent to the date of their last valuation.
(b) Internal Control Over Financial Reporting:
There have been no significant changes in the Company's internal controls
or in other factors since the date of the Chief Executive Officer and Chief
Financial Officer's (or persons performing similar functions) evaluation that
could significantly affect these internal controls during the period covered by
this report or from the end of the reporting period to the date of this Form
10-KSB, including any corrective actions with regards to significant
deficiencies and material weaknesses.
30
PART III
Item 9. Directors, Executive Officers, Promoters and Control Persons; Compliance
with Section 16(a) of the Exchange Act
(a) The following table sets forth the names, ages, positions and address
of our current directors and executive officers.
Name Age Position(s) with Company Election Date
--------------- --- ----------------------------------- --------------
George D. Green 47 Chief Executive Officer, President, December 2004
Secretary and Director(1)
Business Experience
Dr. George D. Green 47, is Chairman of the Board of Directors, President
and Chief Executive Officer of Union Dental Corp. He currently serves as our
sole officer and director. He graduated from the University of Miami in 1983. He
attended Georgetown University School of Dentistry where he graduated in 1985
with his Doctor of Dental Surgery (DDS) degree. Dr. Green started his general
dentistry practice in Florida in 1986 and currently maintains that office. He
has been President of the Coral Springs Business Club from 1993-96 and President
of the Coral Springs/Parkland Rotary Club from 1996-97. He is the Founder of
Union Dental Corp., and has held the management positions of the Company since
inception. Dr. Green has been a Dental Network participant since 1992 in General
Dentistry, Endodontics and Periodontics. In August 2000, he purchased 50%
ownership of DDS and on December 31, 2003, he purchased the remaining 50% of
DDS.
Committees of the Board of Directors
We presently do not have an audit committee, compensation committee,
nominating committee, an executive committee of our board of directors, stock
plan committee or any other committees.
Compensation of Directors
Our directors do not receive cash compensation for their services as
directors or members of committees of the board, but are reimbursed for their
reasonable expenses incurred in attending board or committee meetings.
Terms of Office
There are no family relationships among our directors and/or officers. Our
directors are appointed for one-year terms to hold office until the next annual
general meeting of the holders of our Common Stock or until removed from office
in accordance with our by-laws. Our officers are appointed by our board of
directors and hold office until removed by our board of directors.
Involvement in Certain Legal Proceedings
Except as indicated above, no event listed in Sub-paragraphs (1) through
(4) of Subparagraph (d) of Item 401 of Regulation S-B, has occurred with respect
to any of our present executive officers or directors or any nominee for
director during the past five years which is material to an evaluation of the
ability or integrity of such director or officer.
31
Compliance with Section 16(a) of the Securities Exchange Act of 1934 For
companies registered pursuant to section 12(g) of the Exchange Act, Section
16(a) of the Exchange Act requires our executive officers and directors, and
persons who beneficially own more than ten percent of our equity securities, to
file reports of ownership and changes in ownership with the Securities and
Exchange Commission. Officers, directors and greater than ten percent
shareholders are required by SEC regulation to furnish us with copies of all
Section 16(a) forms they file. To our knowledge, based solely on a review of the
copies of reports furnished to us and written representations that no other
reports were required, Section 16(a) filing requirements applicable to our
officers, directors and greater than ten percent beneficial owners were complied
with on a timely basis for the period which this report relates.
Code of Ethics
On December 28, 2004, we adopted a Code of Ethics that meets the
requirements of Section 406 of the Sarbanes-Oxley Act of 2002. We will provide
to any person without charge, upon request, a copy of such Code of Ethics.
Persons wishing to make such a request should contact George D. Green, Chief
Executive Officer, 1700 University Drive, Suite 200, Coral Springs, Florida
33071.
Indemnification of Officers and Directors.
Our By-Laws provide for the indemnification of our directors, officers,
employees, and agents, under certain circumstances, against attorney's fees and
other expenses incurred by them in any litigation to which they become a party
arising from their association with or activities on behalf of the Company. We
will also bear the expenses of such litigation for any of our directors,
officers, employees, or agents, upon such persons promise to repay the Company
therefor if it is ultimately determined that any such person shall not have been
entitled to indemnification. This indemnification policy could result in
substantial expenditures by us, which we may not be able to recoup.
ITEM 10. EXECUTIVE COMPENSATION
The following table shows all the cash compensation paid by the Company, as
well as certain other compensation paid or accrued, during the fiscal years
ended December 31, 2005, 2004 and 2003 to the Company's President and highest
paid executive officers. No restricted stock awards, long-term incentive plan
payouts or other types of compensation, other than the compensation identified
in the chart below, were paid to these executive officers during these fiscal
years.
[Balance of this page intentionally left blank.]
32
SUMMARY COMPENSATION TABLE
Long Term Compensation
------------------ ------- -------------------------------------- ---------------------- ---------- -------------
Annual Compensation Awards Payouts
------------------ ------- ------------ ---------- -------------- ----------- ---------- ---------- -------------
Other Restricted Securities LTIP All Other
Name and Annual Stock Underlying Payouts Compensation
Principal Year Salary ($) Bonus ($) Compensation Award(s) Options/
Position ($) ($) SARs
------------------ ------- ------------ ---------- -------------- ----------- ---------- ---------- -------------
George D. Green, 2005 190,000
CEO & President 2004 118,000
2003 505,587(1)
Dr. Melvyn
Greenstein 2005 $ -0-
Former 2004 $ -0-
Director (a) 2003 $ 270,259(2)
------------------------------
Except as set forth above, during the last three years received any compensation
from the Company for serving as an officer or directors.
(a) On January 5, 2004, Dr. Melvyn Greenstein resigned from DDS as a director,
president and registered agent. He was succeeded as president and
registered agent by Dr. George D. Green.
(1) In 2003 Dr. George Green received from DDS $235,464.00 and $270,123.00 from
George D. Green, DDS, PA.
(2) In 2003 Dr. Melvyn Greenstein received from DDS $38,321.00 and his
management company (Gopher International) received $231,938.00 from DDS.
Compensation of Directors
We have no standard arrangements for compensating our board of directors
for their attendance at meetings of the Board of Directors.
Bonuses and Deferred Compensation
We do not have any bonus, deferred compensation or retirement plan. Such
plans may be adopted by us at such time as deemed reasonable by our board of
directors. We do not have a compensation committee, all decisions regarding
compensation are determined by our board of directors.
Stock Option Plans.
In June 2005 the Board of Directors adopted the 2005 Equity Compensation
Plan (the "2005 Plan"). The Plan permits the granting of an aggregate of
5,000,000 Shares. The Plan also permits the granting of either incentive or
nonstatutory options. The 2005 Plan was filed with the Securities and Exchange
Commission on Form S-8. During the year ended December 31, 2005, we issued a
total of 1,200,000 shares of our common stock pursuant to the Plan. There were
no incentive or nonstatutory options granted under the Plan.
33
Option Grants in Last Fiscal Year to Executive Officers
Number of % of Total
Securities Options
Underlying Granted to Exercise
Options Employees Price Expiration
Name Granted (#) in Fiscal Year ($/sh) Date
---------------- ----------- -------------- --------- ----------
George D. Green 500,000* 49.6% $0.15 2009
* Dr. Green was initially issued 750,000 options at an exercise price of $.60
per share. On December 30, 2005, the Company cancelled these options and
issued Dr. Green a total of 500,000 options at an exercise price of $0.15
per share. At the time of the grant, the closing bid price of the Company's
common stock was $.10 per share. All options are now fully vested. The
Company has issued a total of 1,008,000 options to various employees
including Dr. Green.
During the year ended 2004, Dr. Green was granted 997,500 performance based
options. These options vest at the market value calculated as of the date the
following revenue milestones are met: 332,500 shares upon the Company reaching
$3,000,000 in revenue, 332,500 shares upon the Company reaching $4,000,000 in
revenue, and 332,500 shares upon the Company reaching $5,000,000 in revenue. The
Company has issued a total of 1,245,000 performance options
On October 15, 2004, the Board of Directors adopted the 2004 Stock Option
Plan (the "2004 Plan"). The 2004 Plan permits the granting of an aggregate of
5,000,000 Shares. As of March 15, 2006 we have issued a total of 1,508,000
options under this Plan at exercise prices ranging from $0.13 to $0.50 per share
plus an additional 1,740,000 performance based options which are issuable at the
then current market price. Under the 2004 Plan, either incentive stock options
or nonstatutory options may be granted as an incentive to key employees
(including directors and officers who are key employees), non-employee
directors, independent contractors and consultants of the Company and to offer
an additional inducement in obtaining the services of such individuals. The Plan
also permits the award of common stock to qualified recipients.
The exercise price of the Shares under each option is determined by a
committee appointed by the Board of Directors; provided, however, that the
exercise price shall not be less than the fair market value of the Shares on the
date of the grant for statutory options. The term of each option granted
pursuant to the 2004 Plans is established by the committee appointed by the
Board of Directors, in its sole discretion, provided that the term shall not
exceed ten years from the date of the grant.
All of the Company's Plans provide that the number of Shares subject
thereto and the outstanding options and their exercise prices are to be
appropriately adjusted for mergers, consolidations, recapitalizations, stock
dividends, stock splits or combinations of shares.
34
The following table summarizes the number and dollar value of unexercised
stock options at March 1, 2006 for the Named Executive Officers.
Shares Value Number of Securities Value of Unexercised
Acquired Realized Underlying Unexercised In-the-Money Options
Name on Exercise (#) ($) Options at FY-End (#) at FY-End ($)(1)
----------------- -------------- ---------- ------------------------- -------------------------
Exercisable/Unexercisable Exercisable/Unexercisable
----------- ------------- ----------- -------------
George D. Green -0- -0- 500,000 997,500 $ -0- -0-*
--------------------------
(1) The closing price of the Company's Shares on March 15, 2006 as reported by
OTC Bulletin Board was $0.07 per Share.
* The value of the exercisable and unexercisable options shall be determined
upon the date of issuance.
Termination of Employment and Change of Control Arrangement
There are no compensatory plans or arrangements, including payments to be
received from us, with respect to any person named in cash compensation set out
above which would in any way result in payments to any such person because of
his resignation, retirement, or other termination of such person's employment
with us or our subsidiaries, or any change in control of us, or a change in the
person's responsibilities following a changing in control.
Item 11. Security Ownership of Certain Beneficial Owners and Management
The following table sets forth, as of March 1, 2006 information with
respect to the beneficial ownership of our common stock by (i) persons known by
us to beneficially own more than five percent of the outstanding shares, (ii)
each director, (iii) each executive officer and (iv) all directors and executive
officers as a group. As of March 1, 2006, there were issued and outstanding
35,334,299 shares of Common Stock and 1,508,000 Shares of Common Stock issuable
upon the exercise of presently exercisable stock options and warrants.
Common Stock
Beneficially Owned
Title of ----------------------------
Name and Address Class Number Percent (3)
--------------------------------------------------------------------------------
George D. Green Common 18,000,000(1)(2) 49.5%
1700 University Drive
Coral Springs, FL 33071
All Executive Officers and
Directors as a Group Common 18,000,000 49.5%
(One (1) person)
--------------------------------------------------------------------------------
35
(1) Includes a total of 75,000 and 50,000 shares which Dr. Green transferred to
his children, Jacyln and Joshua. However, Dr. Green has disclaimed
beneficial ownership of these transferred shares.
(2) Includes options to purchase 500,000 shares which are either currently
exercisable or which become exercisable within 60 days of the date of March
1, 2006. George D. Green holds 1,000,000 shares of our preferred stock that
provides for 15 to 1 voting rights. See Notes to our Financial Statements.
(3) Under Rule 13d-3, a beneficial owner of a security includes any person who,
directly or indirectly, through any contract, arrangement, understanding,
relationship, or otherwise has or shares: (i) voting power, which includes
the power to vote, or to direct the voting of shares; and (ii) investment
power, which includes the power to dispose or direct the disposition of
shares. Certain shares may be deemed to be beneficially owned by more than
one person (if, for example, persons share the power to vote or the power
to dispose of the shares). In addition, shares are deemed to be
beneficially owned by a person if the person has the right to acquire the
shares (for example, upon exercise of an option) within 60 days of the date
as of which the information is provided. In computing the percentage
ownership of any person, the amount of shares outstanding is deemed to
include the amount of shares beneficially owned by such person (and only
such person) by reason of these acquisition rights. As a result, the
percentage of outstanding shares of any person as shown in this table does
not necessarily reflect the person's actual ownership or voting power with
respect to the number of shares of common stock actually outstanding on
March 1, 2006. As of March 1, 2006, there were 35,334,299 shares of our
common stock issued and outstanding.
Item 12. Certain Relationships and Related Transactions
Except as described below, none of the following persons has any direct or
indirect material interest in any transaction to which we are a party during the
past two years, or in any proposed transaction to which the Company is proposed
to be a party:
(A) any director or officer;
(B) any proposed nominee for election as a director;
(C) any person who beneficially owns, directly or indirectly, shares
carrying more than 5% of the voting rights attached to our common
stock; or
(D) any relative or spouse of any of the foregoing persons, or any
relative of such spouse, who has the same house as such person or who
is a director or officer of any parent or subsidiary.
UDC entered into a Management Services Agreement and a Business Associate
Agreement with Dr. George D. Green, DDS, P.A. ("Green PA") on October 15, 2004.
Pursuant to these agreements, UDC shall manage the operations of Green PA for a
management fee pursuant to the agreements.
On March 20, 2004, UDC, a wholly owned subsidiary of the Company, entered
into an employment agreement with Dr. Green, the sole officer of UDC and our
chief executive officer, for a term of seven years. The agreement provides for a
36
base salary to Dr. Green of $225,000 in year one, $125,000 in year two, $185,000
in year three, $196,630 in year four, $208,427 in year five, $220,932 in year
six and $234,187 in year seven. The agreement also provides for the issuance of
options to Dr. Green upon signing, 750,000 options with an exercise price of
$0.60 per share, half vested immediately and half vesting after two years,
having an exercise life of five years. The agreement also provides for the
issuance of options to Dr. Green as well, if certain revenue milestones are
reached: If we achieve gross revenues of $3,000,000 in for any calendar year,
Dr. Green will be issued 332,500 options with an exercise price at the market
price of the underlying common stock at issue date. Additional options pursuant
to the same terms and conditions will be issued if the Company achieves
$4,000,000 and again at $5,000,000 in gross revenue for any calendar year.
On October 15, 2004, Dr. Green sold his interest in his dental practice to
UDC, an entity that he previously controlled, for $1,000,000, which amount was
recorded by the Company as a shareholder loan. Specifically, in the financial
statement presentation, the amount of the purchase price that exceeded the net
book value of the dental practice assets acquired has been treated as a
shareholder loan. This amount was deducted from the Company's stockholder's
equity because the transaction was with a related party and such amount is not
reflective of any funds due from Dr. Green.
In 2004 we incurred a charge to stockholders' equity in the amount of
$1,539,129. This charge was a result of three related party transactions. First,
UDC issued a $1 million note payable to Dr. Green, our controlling shareholder,
as consideration for the purchase of the assets (minus the client list) of his
dental practice, Dr. George D. Green, DDS, P.A. The Second transaction related
to DDS executed a note payable to a bank in the amount of $1,215,000 to satisfy
an outstanding liability of Dr. Green to purchase shares of DDS prior to the
Reorganization. These amounts are offset by $675,871, representing a note
receivable from Dr. Green resulting from the above transactions, net of other
payables.
In December 2005, the Company cancelled the 750,000 options previously
granted to Dr. Green with an exercise price of $.60 per share in consideration
for the grant of 500,000 options at an exercise price of $.15 per share. At the
time of the cancellation and grant, our common stock was trading at $.10 per
share.
UDC entered into an employment agreement with Robert Gene Smith on February
15, 2004, pursuant to which Mr. Smith became a member of the Board of Directors
of UDC and received an annual compensation of $24,000. The current agreement
expired February 15, 2006. The parties have verbally agreed to extend the
agreement on an annual basis pursuant to the same terms and conditions. However,
it can be cancelled at any time by the Company on written notice to Mr. Smith.
Mr. Smith was previously granted 250,000 options to purchase shares of common
stock at $0.50 per share and an additional 247,500 options dependent upon the
achievement of certain revenue milestones.
37
Item 13. Exhibits and Reports on Form 8-K.
(a) The exhibits required to be filed herewith by Item 601 of Regulation
S-B, as described in the following index of exhibits, are either filed herewith
or incorporated herein by reference.
Exhibit
No. Description
-------- ----------------------------------------------------
2.2 Share Exchange Agreement between Shava, Inc. and National Business
Holdings, Inc. dated May 28, 2004.
2.3 Reorganization Agreement, dated December 28, 2004, by and among the
Company, Union Dental, DDS and the shareholders of Union Dental and
DDS. (4)
2.4 Asset Purchase Agreement dated October 15, 2004 by and among Union
Dental and George D. Green, DDS, P.A. (4)
3(i).1 Amended and Restated Articles of Amendment to the Articles of
Incorporation of Mecaserto, Inc., A Florida Corporation
3(i).2 Articles of Incorporation of National Business Investors, Inc.
3(i).3 Articles of Incorporation of Union Dental Corp.(5)
3(i).4 Articles of Incorporation of Direct Dental Services, Inc. (5)
3(ii).1 Bylaws of National Business Holdings, Inc. (5)
3(ii).2 Bylaws of Union Dental Corp. (5)
3(ii).3 Bylaws of Direct Dental Services, Inc.
4.1 Form of Option issued to Union Dental optionholders. (4)
16.1 Letter from Lawrence Scharfman, CPA, P.A. (3)
10.1 Business Associate Agreement dated October 15, 2004 by and among Union
Dental and George D. Green, DDS, P.A. (5)
10.2 Management Services Agreement dated October 15, 2004 by and among
Union Dental and George D. Green, DDS, P.A. (5)
10.3 Employment Agreement dated March 20, 2004 by and among Union Dental
and Dr. George D. Green. (4)
10.4 Employment Agreement dated October 26, 2004 by and among Union Dental
and Dr. Leonard I. Weinstein. (4)
38
10.5 Shareholder's Agreement and Management Contract by and among Union
Dental and Tropical Medical Services. (4)
10.6 Employment Agreement dated February 15, 2004 by and among Union Dental
and Robert Gene Smith. (4)
10.7 2004 Stock Option Plan for Union Dental (4)
10.8 Form of Management Service Agreement with Participating Dentists
10.9 Form of Service Agreement with Participating Unions
10.10 Debenture Agreement executed between the Company and Dutchess Private
Equities Fund II, L.P. (6)
10.11 Registration Rights Agreement between the Company and Dutchess Private
Equities Fund II, L.P. (6)
10.12 Warrant Registration Rights Agreement between the Company and Dutchess
Private Equities Fund II, L.P. (6)
10.13 Equity Line of Credit Registration Rights Agreement between the
Company and Dutchess Private Equities Fund II, L.P. (6)
10.14 Investment Agreement between the Company and Dutchess Private Equities
Fund II, L.P. (6)
10.15 Debenture Agreement between the Company and Dutchess Private Equities
Fund II, L.P. (7)
14.1 Code of Ethics (4)
16.1 Letter from Lawrence Scharfman to the Securities and Exchange
Commission dated January 3, 2005 (4)
17.1 Letter of Resignation of Dr. Melvyn Greenstein (4)
17.2 Letter of Resignation of Roger E. Pawson (4)
31 * Certificate of the Chief Executive Officer and Chief Financial Officer
pursuant Section 302 of the Sarbanes-Oxley Act of 2002
32 * Certificate of the Chief Executive Officer and Chief Financial Officer
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
---------------------------
(1) Filed as Exhibits 2.1, 2.2, 2.3 to the Company's Form 10-SB filed with the
Securities and Exchange Commission on July 14, 1999, and incorporated by
Reference herein.
(2) Filed as Exhibit 3.1 to the Company's Form 8-K filed with the Securities
and Exchange Commission on March 10, 2003, and incorporated by reference
herein.
(3) Filed as Exhibits 16.1 and 16.2 to the Company's Form 8-K filed with the
Securities and Exchange Commission on February 26, 2004.
39
(4) Filed as Exhibits to the Company's Form 8-K filed with the Securities and
Exchange Commission on January 4, 2005.
(5) Filed as Exhibits to the Company's Form 8-K/A filed with the Securities and
Exchange Commission on February 4, 2005.
(6) Filed as an exhibit to the Company's Form 8-k filed August 22, 2005.
(7) Filed as an exhibit to the Company's Form 8-k filed December 27, 2005
------------------
* Included herein
(b) Reports on Form 8-k. During the last quarter of the fiscal year ended
December 31, 2005, we filed on December 27, 2005 a report on Form 8-k,
disclosing the terms and conditions of a $960,000 ("Face Amount") promissory
note with Dutchess.
ITEM 14. PRINCIPLE ACCOUNTANT FEES AND SERVICES
AUDIT FEES. The aggregate fees billed for professional services rendered
was $27,831 and $39,040 for the audit of our annual financial statements for the
fiscal years ended December 31, 2005 and 2004, respectively, and the reviews of
the financial statements included in our Forms 10-QSB for those fiscal years.
AUDIT-RELATED FEES. There were no fees billed in each of the last two
fiscal years for assurance and related services by the principal accountant that
are reasonably related to the performance of the audit or review of our
financial statements and not reported under the caption "Audit Fee."
TAX FEES. No fees were billed in each of the last two fiscal years for
professional services rendered by the principal accountant for tax compliance,
tax advice and tax planning services.
ALL OTHER FEES. Other than the services described above, there were no
other services provided by our principal accountants. for the fiscal years ended
December 31, 2005 and 2004.
We have no formal audit committee. However, our entire Board of Directors
(the "Board") serves in the capacity of the audit committee. In discharging its
oversight responsibility as to the audit process, the Board obtained from the
independent auditors a formal written statement describing all relationships
between the auditors and us that might bear on the auditors' independence as
required by Independence Standards Board Standard No. 1, "Independence
Discussions with Audit Committees." The Board discussed with the auditors any
relationships that may impact their objectivity and independence, including fees
for non-audit services, and satisfied itself as to the auditors' independence.
The Board also discussed with management and the independent auditors the
quality and adequacy of its internal controls. The Board reviewed with the
independent auditors their management letter on internal controls.
The Board discussed and reviewed with the independent auditors all matters
required to be discussed by auditing standards generally accepted in the United
States of America, including those described in Statement on Auditing Standards
No. 61, as amended, "Communication with Audit Committees". The Board reviewed
the audited consolidated financial statements of the Company as of and for the
year ended December 31, 2005 with management and the independent auditors.
40
Management has the responsibility for the preparation of the Company's financial
statements and the independent auditors have the responsibility for the
examination of those statements. Based on the above-mentioned review and
discussions with the independent auditors and management, the Board of Directors
approved the Company's audited consolidated financial statements and recommended
that they be included in its Annual Report on Form 10-KSB for the year ended
December 31, 2004, for filing with the Securities and Exchange Commission.
SIGNATURES
In accordance with the Exchange Act, this report has been signed below by
the following persons on our behalf and in the capacities and on the dates
indicated.
Date: March 30, 2006
Union Dental Holdings, Inc.
----------------------------------------
(Registrant)
By: /s/ GEORGE D. GREEN
----------------------------------
GEORGE D. GREEN, President and Director
Pursuant to the requirements of the Exchange Act, this Report has been
signed below by the following persons on behalf of the Registrant and in the
capacities and on the dates indicated.
Signature Title Date
/s/ GEORGE D. GREEN CEO, President & Director March 30, 2006
-----------------------------
GEORGE D. GREEN
41
INDEX TO FINANCIAL STATEMENTS
Reports of Independent Registered Public Accounting Firms ...................F-2
Consolidated Balance Sheet...................................................F-3
Consolidated Statements of Operations........................................F-4
Consolidated Statements of Stockholders' Equity..............................F-5
Consolidated Statements of Cash Flows........................................F-7
Notes to Consolidated Financial Statements...................................F-8
F-1
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors
Union Dental Holdings, Inc. and Subsidiaries
Coral Springs, Florida
We have audited the accompanying consolidated balance sheet of Union Dental
Holdings, Inc. and Subsidiaries as of December 31, 2005 and the related
consolidated statements of operations, changes in stockholders' equity (deficit)
and cash flows for the years ended December 31, 2005 and 2004. These
consolidated financial statements are the responsibility of the Company's
management. Our responsibility is to express an opinion on these consolidated
financial statements based on our audits.
We conducted our audits in accordance with the standards of the Public
Company Accounting Oversight Board (United States). Those standards require that
we plan and perform the audit to obtain reasonable assurance about whether the
financial statements are free of material misstatement. The Company is not
required to have, nor were we engaged to perform, an audit of its internal
control over financial reporting. Our audit included consideration of internal
control over financial reporting as a basis for designing audit procedures that
are appropriate in the circumstances, but not for the purposes of expressing an
opinion on the effectiveness of the Company's internal control over financial
reporting. Accordingly, we express no such opinion. An audit includes examining
on a test basis, evidence supporting the amount and disclosures in the
consolidated financial statements. An audit also includes assessing the
accounting principles used and significant estimates made by management, as well
as evaluating the overall financial statement presentation. We believe that our
audits provide a reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred to above
present fairly, in all material respects, the financial position of Union Dental
Holdings, Inc. and Subsidiaries as of December 31, 2005, and the results of
their operations and their cash flows for the years ended December 31, 2005 and
2004, in conformity with accounting principles generally accepted in the United
States of America.
The accompanying consolidated financial statements have been prepared
assuming the Company will continue as a going concern. As discussed in Note 10
to the consolidated financial statements, the Company has accumulated losses
from operations of $1,612,178, a working capital deficiency of $1,294,563, a
stockholders' deficit of $1,804,384 at December 31, 2005 and for the year ended
December 31, 2005, used cash in operations of $525,016. These conditions raise
substantial doubt about the Company's ability to continue as a going concern.
Management's plans in regard to these matters are also described in Note 10. The
consolidated financial statements do not include any adjustments that might
result from the outcome of this uncertainty.
/s/ De Meo, Young, McGrath
Certified Public Accountants
Fort Lauderdale, Florida
March xx, 2006
F-2
UNION DENTAL HOLDINGS, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEET
December 31, 2005
ASSETS
CURRENT ASSETS:
Cash $ 557,272
Accounts receivable, less allowance for doubtful accounts of $69,700 310,833
Inventory of supplies 28,885
Prepaid expenses and other current assets 4,646
-------------------
Total current assets 901,636
Property and equipment, net 293,925
Debt issuance costs, net 126,275
Other assets 15,713
-------------------
Total Assets $ 1,337,549
===================
LIABILITIES AND SHAREHOLDERS' DEFICIT
CURRENT LIABILITIES:
Note payable, net $ 25,475
Convertible debenture payable, net 206,491
Note payable - bank 1,268,667
Accounts payable 19,886
Accrued expenses 65,380
Customer deposits 35,997
Unearned membership fees 313,374
Derivates liability 1,414,593
-------------------
Total current liabilities 3,349,863
-------------------
Commitments and contingencies
SHAREHOLDERS' DEFICIT:
Preferred stock ($.0001 Par value; 25,000,000 share authorized;
1,000,000 shares issued and outstanding) 100
Common stock ($.0001 Par value; 300,000,000 share authorized;
33,676,303 shares issued and outstanding) 3,368
Additional paid-in capital 1,309,007
Accumulated deficit (1,820,108)
Shareholder transactions (1,489,711)
Less: deferred compensation (14,970)
-------------------
Total shareholders' deficit (2,012,314)
-------------------
Total liabilities and shareholders' deficit $ 1,337,549
===================
See accompanying notes to consolidated financial statements.
F-3
UNION DENTAL HOLDINGS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
For the Years Ended
December 31,
-----------------------------------------------
2005 2004
---------------------- ----------------------
Revenues, net $ 2,066,944 $ 1,931,570
---------------------- ----------------------
Operating Expenses:
Cost of services performed 488,187 382,967
Salaries and related taxes 843,204 692,099
Depreciation and amortization 39,467 9,880
Professional fees 199,018 106,336
Consulting fees 373,215 92,405
Other general and administrative 762,057 594,570
---------------------- ----------------------
2,705,148 1,878,257
---------------------- ----------------------
(Loss) income from operations (638,204) 53,313
---------------------- ----------------------
Other income (expense):
Amortization of debt issuance costs (6,725) -
Loss from valuation of derivatives liability (273,731) -
Impairment of goodwill - (7,750)
Interest income - 13
Interest expense (521,523) (40,587)
---------------------- ----------------------
Total other income (expense) (801,979) (48,324)
---------------------- ----------------------
Net (loss) income $ (1,440,183) $ 4,989
====================== ======================
Net loss per common share:
Net loss per common share - basic and diluted $ (0.05) $ 0.00
====================== ======================
Weighted average common shares outstanding - basic 29,702,912 27,511,177
====================== ======================
Weighted average common shares outstanding - diluted 29,702,912 28,261,112
====================== ======================
See accompanying notes to consolidated financial statements.
F-4
UNION DENTAL HOLDINGS, INC. AND SUBSIDIARIES
STATEMENTS OF CHANGES IN SHAREHOLDER' EQUITY (DEFICIT)
FOR THE YEARS ENDED DECEMBER 31, 2005 and 2004
Preferred Stock Common Stock
$.0001 Par Value $.0001 Par Value
-----------------------------------------------
Number of Number of Paid-in
Shares Amount Shares Amount Capital
----------------------------------------------------------
Balance - December 31, 2003 1,000,000 $ 100 17,500,000 $ 1,750 $ (850)
Recapitalization of Company - - 10,000,000 1,000 10,145
Distributions to prior shareholders of
S-Corporation - - - - -
Common stock issued for debt
conversion at $.50 per share - - 913,939 91 456,783
Common stock issued under
consulting agreement - - 106,000 11 52,989
Net income for the year - - - - -
----------------------------------------------------------
Balance - December 31, 2004 1,000,000 100 28,519,939 2,852 519,067
Common stock in connection
with note payable - - 1,500,000 150 134,850
Common stock issued for
acquisition of assets - - 733,901 74 113,681
Common stock issued for
debenture conversion - - 590,000 59 54,221
Common stock issued for interest - - 53,817 5 4,947
Common stock issued for services
- - 2,158,646 216 238,237
Warrant value related to
debenture payable - - - - 124,138
Common stock issued in
private placement - - 120,000 12 59,988
Grant of stock options - - - - 59,878
Repayment of shareholder loan - - - - -
Net loss for the year - - - - -
----------------------------------------------------------
Balance - December 31, 2005 1,000,000 $ 100 33,676,303 $3,368 $1,309,007
==========================================================
See accompanying notes to consolidated financial statements.
F-5
UNION DENTAL HOLDINGS, INC. AND SUBSIDIARIES
STATEMENTS OF CHANGES IN SHAREHOLDER' EQUITY (DEFICIT)
FOR THE YEARS ENDED DECEMBER 31, 2005 and 2004
(Continued)
Additional Total
Accumulated Shareholder Deferred Stockholders'
Deficit Transactions Compensation Equity (Deficit)
-------------------------------------------------------------------------
$ 236,050 $ - $ - $ 237,050
(236,050) (1,539,129) - (1,764,034)
(384,914) - - (384,914)
- - - 456,874
- - - 53,000
4,989 - - 4,989
-------------------------------------------------------------------------
(379,925) (1,539,129) - (1,397,035)
- - - 135,000
- - - 113,755
- - - 54,280
- - - 4,952
- - - 238,453
- - - 124,138
- - - 60,000
- (14,970) 44,908
- 49,418 - 49,418
(1,440,183) - - (1,440,183)
-------------------------------------------------------------------------
$(1,820,108) $ (1,489,711) $ (14,970) $ (2,012,314)
=========================================================================
See accompanying notes to consolidated financial statements.
F-6
UNION DENTAL HOLDINGS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
For the Years Ended
December 31,
--------------------------------------
2005 2004
----------------- -------------------
Cash Flows From Operating Activities:
Net (loss) income $ (1,440,183) $ 4,989
Adjustments to reconcile net (loss) income to net cash
provided by (used in) operating activities:
Depreciation and amortization 39,467 9,880
Stock-based compensation and consulting 283,361 111,763
Common stock issued for interest 4,952
Provision for bad debt 62,500 7,200
Impairment of goodwill - 7,750
Amortization of debt issuance costs 6,725 -
Amortization of discount of debenture and note payable 401,927 -
Loss from valuation of derivatives 273,731 -
Changes in assets and liabilities:
Accounts receivable (56,256) (51,504)
Inventory of supplies (4,830) -
Prepaid expenses and other current assets (1,137) 10,300
Other assets (5,200) (10,513)
Accounts payable (36,857) 136,205
Accrued expenses 65,380 -
Due to related parties (110,839) (279,525)
Customer deposits 5,195 4,189
Unearned membership fees (12,952) 61,663
----------------- -------------------
Net cash provided by (used in) operating activities (525,016) 12,397
----------------- -------------------
Cash Flows From Investing Activities:
Purchase of property and equipment (170,161) (12,603)
Cash acquired in reorganization - 2,000
----------------- -------------------
Net cash used in investing activities (170,161) (10,603)
----------------- -------------------
Cash Flows From Financing Activities:
Net proceeds from sales of common stock 60,000 -
Distribution to shareholders' - (384,914)
Proceeds from note payable 800,000 -
Payment on short-term debt (50,581) 417,006
Proceeds from line of credit - 47,813
Proceeds from debenture payable 600,000 -
Payment on debenture payable (115,682) -
Payment of placement fees (133,000) -
Repayment of other stockholder transaction 49,418 -
Payments on notes payable - (56,061)
----------------- -------------------
Net cash provided by financing activities 1,210,155 23,844
----------------- -------------------
Net increase in cash 514,978 25,638
Cash - beginning of year 42,294 16,656
----------------- -------------------
Cash - end of year $ 557,272 $ 42,294
================= ===================
Supplemental Disclosures of Cash Flow Information
Cash payments for interest $ 114,644 $ 624
================= ===================
Cash payments for income taxes $ $ -
================= ===================
Non-cash investing and financing activities:
Issuance of common stock for debt $ 54,280 $ 417,006
================= ===================
Stockholder loan offset in stockholder transactions $ - $ 560,179
================= ===================
Common stock issued for asset acquisition $ 113,755 $ -
================= ===================
Common stock issued in connection with promissory note $ 135,000 $ -
================= ===================
Warrants granted in connection with discount of debentures $ 124,138 $ -
================= ===================
Derivitives liabilty reflected as discount to debenture
and note payable $ 1,140,862 $ -
================= ===================
See accompanying notes to consolidated financial statements.
F-7